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1 Preface
In gene expression or proteomic studies mostly a large number of hypotheses are investigated.
As compared to the large number of hypotheses (genes or proteins) to be tested, only for
a small number of hypotheses noticeable eﬀects exist. Two problems that may arise in this
context are:
1. ﬁnding diﬀerentially expressed genes (proteins) among a large number of
hypotheses and
2. ﬁnding prognostic scores to predict the clinical outcome of future patients.
This thesis consists of two parts. The ﬁrst part investigates the problem to select the few
genes (proteins) with an eﬀect among up to thousands of candidates. Due to limited re-
sources, the number of observations per hypotheses in conventional single-stage designs are
low which limits the power. It has been shown that two-stage designs are a good option
to improve the power. In these sequential designs, the ﬁrst stage is used to screen for the
promising hypotheses, which are further investigated in the second stage. Two-stage pilot
designs only use second stage data and two-stage integrated designs use pooled data from
both stages for the ﬁnal test decisions on the screened hypotheses.
In genomic or proteomic studies there is an increasing focus on using a less accurate assay in
early stages and a more accurate one in later stages. This thesis more thoroughly investigates
this type of two-stage designs where the costs per measurement and eﬀect sizes diﬀer between
the ﬁrst and second stage. To compare diﬀerent designs it is assumed that the total costs of
the experiment are ﬁxed. Both integrated and pilot designs are based on procedures either
controlling the Family Wise Type I Error Rate (FWER) or the False Discovery Rate (FDR).
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Asymptotically optimal designs will be derived and their statistical properties will be described.
Two scenarios are considered: In the ﬁrst scenario the same method is applied in both stages
but diﬀerent costs per measurement may arise at both stages because speciﬁc experimental
devices have to be produced at higher costs per measurement for the selected markers at the
second stage. Furthermore the robustness of the optimal two-stage designs against misspec-
iﬁcations in the planning phase with regard to the proportion of true null hypotheses and the
true eﬀect size is investigated. In the second scenario the experimenter from the beginning
may have the choice between two methods that diﬀer in costs and eﬀect sizes (a low-cost
standard method or a high-cost improved method).
As extension, cases under less stringent distributional assumptions like unknown variance and
correlation between hypotheses are investigated. Finally the constraint of integer stage wise
sample sizes is discussed.
In the second part of the thesis, the problem of selecting and estimating a score from a
large set of gene or protein measurements to allow prediction of a clinical outcome is dis-
cussed. Such a situation arises, e.g., if genetic measurements are available in samples of
patients responding or not responding to a particular therapy respectively and these samples
are used as a training set to construct a score for prognosis of the response of future inde-
pendent patients. The prognostic ability of scores developed in this way will be studied for
diﬀerent selection methods. We tackle the question what we can expect, if in samples of
patients responding and not responding to a particular therapy, markers are selected and used
to construct a score for prediction of response in future patients. Prognostic scores based
on three selection procedures are discussed:
1. Multiple testing of individual hypotheses controlling the FDR
2. Selecting the k "best" markers
3. Using a stepwise selection procedure
We simulated scenarios for diﬀerent choices of the FDR and k and for diﬀerent thresholds for
a forward logistic regression. The predictive ability of such estimated scores is investigated
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by simulating their Receiver Operating Characteristics (ROC) in an independent future pa-
tient. The diﬀerent selection procedures are compared using the area under the ROC (AUC).
We investigated the predictive abilities under the assumption of independent hypotheses with
known variance. Additionally the situation is considered that cross validation is used to de-
termine decision boundaries for the test based selection procedures optimal with regard to
the area under the ROC-curve (AUC), thus achieving some information on the extent of false
positive decisions.
Outline of the thesis:
The ﬁrst part of the thesis is based on the following published paper:
Goll and Bauer (2007): Two-stage designs applying methods diﬀering in costs,
Bioinformatics, 23: 1519-1526.
A few results of the second part of the thesis have been used and cited in
Bauer (2008): Adaptive designs: looking for a needle in the haystack - a new challenge
in medical research, Statistics in Medicine, to appear.
A short summary of the ﬁrst part can also be seen in Zehetmayer, Goll, Bauer and Posch
(2007): Step by Step: mehr Eﬃzienz mit neuen Studiendesigns, Biospektrum, 7: 754-755.
The two topics of the thesis consider two problems that may arise in genomic or proteomic
studies. Hence after an introduction to the general methodology the two topics are treated
in two separate sections of the thesis. Each section has its own speciﬁc introduction to the
topic and concluding remarks. The relevant literature for the whole thesis is added at the end.
Availability:
R-programs (R (2005)) concerning the ﬁrst part of the thesis to calculate asymptotically
optimal designs are available on:
http://statistics.msi.meduniwien.ac.at/index.php?page=ao2stage
These R-programs can also be seen in the appendix.
3
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2 Multiple hypothesis testing
When a single null hypotheses H is tested, a Type I error, that is rejecting the hypotheses,
when it is in fact true (a false positive decision) may occur. A standard approach is to specify
an acceptable level  for the probability of a Type I error. Let H = 0 if the null hypotheses is in
fact true, and H = 1 if the alternative holds. The control of a speciﬁed Type I error probability
 can be achieved by choosing a critical value c such that P (T  c j H = 0)  , where
T is the corresponding test statistic for hypothesis H. The hypothesis H is rejected if T  c.
If the hypothesis is accepted, although in fact the alternative holds, a Type II error oc-
curs (a false negative decision). The probability of a Type II error is:  = P (T < c j H = 1):
Multiple testing refers to the testing of more than one hypothesis at the same time. For
example in genomic or proteomic experiments thousands of hypotheses are tested simulta-
neously. Since the probability of at least one Type I error increases with the number of
hypotheses, in such studies large multiplicity problems occur. Therefore, problems that arise
from the multiplicity aspect are:
 deﬁning a Type I error rate and
 developing powerful multiple testing procedures that control this error rate.
5
2 Multiple hypothesis testing
Table 2.1: Possible outcomes after a multiple testing procedure
Number of not rejected rejected Total
True null hypotheses U V m0
False null hypotheses T S m(1  0)
Total m-R R m
2.1 Error rates
Consider the problem of testing simultaneously m null hypotheses Hi , i = 1; :::; m and denote
by R the number of rejected hypotheses among the m hypotheses. Assume that there are
m0 true null hypotheses among all m hypotheses. The proportion of true null hypotheses
0 is an unknown parameter. Table 2.1 describes the various outcomes when applying a
multiple testing procedure to perform m hypothesis tests (compare Benjamini and Hochberg
(1995)). The number of rejected hypotheses R is an observed random variable and S (number
of true positive decisions), T (number of false negative decisions), U (number of true neg-
ative decisions) and V (number of false positive decisions) are unobservable random variables.
In the literature numerous diﬀerent error rates and procedures for the control of these er-
ror rates are described. In the following two important error rates for the multiple testing
situation are speciﬁed:
 The Family Wise Error Rate (FWER) is deﬁned as the probability of at least one
Type I error:
FWER = P (V  1): (2.1)
 The False Discovery Rate (FDR) is the expected proportion of Type I errors among
the rejected hypotheses:
FDR = E
[
V
R
j R > 0
]
P (R > 0) = E
[
V
max(R; 1)
]
: (2.2)
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The eﬀectmax(R; 1) in the denominator is to set V=R = 0 if R = 0 (compare Benjamini
and Hochberg (1995)).
Beside the FWER and the FDR, e.g. the Per-Comparison Error Rate (PCER = E(V )=m),
the Per-Family Error Rate (PFER = E(V )) as well as the positive False Discovery Rate
(pFDR = E[V=R j R > 0]) proposed by Storey (2003) are described in the literature.
A multiple testing procedure is said to control a particular Type I error rate at level  if
this error rate is less than or equal to .
There is a distinction between strong and weak control of a Type I error rate. Strong control
refers to the control of the Type I error rate under any combination of true and false null
hypotheses. In contrast, weak control refers to the control of the Type I error rate only under
the complete null hypotheses, that is when all null hypotheses are in fact true (0 = 1). Weak
control is unsatisfactory, because in reality, some null hypotheses may be true and others false,
but the subset of true null hypotheses is unknown. Strong control ensures that the Type I
error rate is controlled under the unknown combination of true and false null hypotheses.
Under the complete null hypotheses the FDR is equal to the FWER (see Benjamini and
Hochberg (1995)). Therefore control of the FDR implies control of the FWER in the weak
sense. If 0 < 1, the FDR is smaller than or equal to the FWER. Thus, procedures that con-
trol the FWER are more conservative, that is, lead to fewer rejections than those controlling
the FDR. If a procedure only controls the FDR, more Type I errors but less Type II errors
occur and thus, the power of the procedure may be increased. In the long run there is always
a fraction of at most  true null hypotheses among the rejected hypotheses.
Within the class of multiple testing procedures that control a given Type I error rate at
an acceptable level , one seeks for test procedures that maximize the power (1 ), that is,
minimize the Type II error rate (). As with Type I error rates, the concept of power can be
generalized in various ways when moving from single to multiple hypotheses testing. Three
common power deﬁnitions are (compare Dudoit, Shaﬀer and Boldrick (2003)):
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 the probability of rejecting at least one false null hypothesis:
P (S  1) = P (T  m(1  0)  1)
 the average probability of rejecting all false null hypotheses:
E[S]=(m(1  0))
 the probability of rejecting all false null hypotheses:
P (S = m(1  0)) = P (T = 0)
A number of articles can be found, where the problem of multiple testing is investigated for
classical single-stage designs (e.g. Shaﬀer (1995)) or especially for the microarray setting
(e.g. Dudoit et al. (2003) or Tusher, Tibshirani and Chu (2001)). Futschik and Posch (2005),
for example, studied the problem on deciding on the number of hypotheses to be considered
in a multiple hypothesis testing framework when the overall number of observations that can
be collected is ﬁxed. They showed that the expected number of detected eﬀects can be
increased by randomly selecting a smaller number of hypotheses such that more observations
for each hypothesis are available.
2.2 Procedures controlling the family wise error rate
As mentioned before, the Family Wise Error Rate is deﬁned as the probability of making at
least one Type I error (see formula (2.1)). Well known general procedures controlling the
FWER are the Bonferroni and the Bonferroni-Holm procedure which will further be explained.
There are also other procedures, like the Sidak procedure, which is closely related to the
Bonferroni procedure but is slightly less conservative or Hochbergs procedure, which can be
viewed as step-up analog of Holm's step-down procedure, since the ordered p-values are
compared to the same critical values in both procedures (see also Dudoit et al. (2003)).
8
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2.2.1 The Bonferroni procedure
This procedure rejects any hypothesis Hi with a p-value less than or equal to =m. The
Bonferroni procedure is a single-step procedure, that means that equivalent multiplicity ad-
justments are performed for all hypotheses, regardless of the ordering of the test statistics
or p-values. Each hypothesis is evaluated using a critical value that is independent of the
result of tests of other hypotheses. The Bonferroni adjustment provides strong control of
the FWER at level  since the actual probability of rejecting at least one null hypothesis is
less than the nominal FWER level  (see e.g. Dudoit et al. (2003)). However, the power of
this multiple testing procedure decreases strikingly with an increasing number of hypotheses
m.
2.2.2 The Bonferroni-Holm procedure
The Bonferroni-Holm procedure is a step-down procedure, that means the hypotheses that
correspond to the smallest p-values or largest absolute test statistics are considered succes-
sively, with further tests depending on the outcomes of earlier ones. As soon as one fails to
reject a null hypothesis, no further hypotheses are rejected. For the strong control of the
FWER at level , this method proceeds as follows:
1. Let p1  :::  pm denote the observed ordered p-values and let H1; :::; Hm denote the
corresponding null hypotheses.
2. Calculate k^ = minf1  j  m : pj > =(m   j + 1)g.
3. If k^ exists, then reject the null hypotheses Hj , for j = 1; :::; k^   1.
Otherwise, reject all hypotheses.
The Bonferroni-Holm procedure is less conservative than the standard Bonferroni procedure.
9
2 Multiple hypothesis testing
2.3 Procedures controlling the false discovery rate
In the genomic or proteomic setting, where thousands of tests are performed simultaneously
and only a small number of genes or proteins are expected to be diﬀerentially expressed, FDR
controlling procedures present a promising alternative to FWER approaches. In such situa-
tions, controlling the FWER can lead to unduly conservative procedures. One may tolerate
some Type I errors, provided their number is small in comparison to the number of rejected
hypotheses. The FDR, that is the expected proportion of Type I errors among the rejected
hypotheses (see formula (2.2)), oﬀers a less strict multiple testing criterion than the FWER.
This diﬀerent approach to multiple testing was proposed by Benjamini and Hochberg (1995).
Two approaches to provide FDR controlling procedures are the following: One is to ﬁx the
acceptable FDR level beforehand, and ﬁnd a data-dependent thresholding rule so that the
FDR of this rule is less than or equal to the pre-chosen level. This is the approach taken by
Benjamini and Hochberg (1995). Another is to ﬁx the thresholding rule and form an estimate
of the FDR whose expectation is greater than or equal to the true FDR over that signiﬁcance
region. This is the approach taken by Storey (2002). These two procedures are discussed in
the following.
2.3.1 The Benjamini-Hochberg procedure
Benjamini and Hochberg (1995) derived the following step-up procedure for strong control
of the FDR for independent test statistics. In contrast to step-down procedures, step-up
procedures begin with the largest p-value. Benjamini and Hochberg proved that the following
procedure controls the FDR at a pre-chosen level  when the p-values following the null
distribution are independent and uniformly distributed. This method proceeds as follows:
1. Let again p1  :::  pm denote the observed ordered p-values corresponding to the
hypotheses H1; :::; Hm.
2. For the control of the FDR at level  calculate
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k^ = maxf1  k  m : pk  kmg.
3. If k^ exists, then reject the null hypotheses Hj for j = 1; :::; k^ corresponding to
p1  :::  pk^ . Otherwise, reject nothing.
It can be shown that the Benjamini-Hochberg procedure controls the FDR in the strong sense
(see Storey, Taylor and Siegmund (2004)). Benjamini and Yekutieli (2001) proved that this
procedure also controls the FDR when the test statistics have positive dependency on each of
the test statistics corresponding to the true null hypothesis. They also proposed, referring to
Hommel (1988), a simple conservative modiﬁcation of the procedure, replacing k=m with
k=(m
∑m
j=1
1
j
) in the second step, which provides FDR control under arbitrary dependence
structures (see also Dudoit et al. (2003)).
The Benjamini-Hochberg procedure was originally introduced by Simes (1986) to weakly
control the FWER when all p-values are independent, although it happens to provide strong
control of the FDR.
2.3.2 Storey's procedure
As mentioned before, instead of ﬁxing  and estimating the rejection region, Storey (2002)
ﬁxed the rejection region and then estimated the FDR. Storey's method uses information
about 0, which yields a less stringent procedure and more power, while maintaining strong
control. Typically the power of a multiple test procedure decreases with increasing m. But
the larger m, the more information about 0 is obtained.
Again m identical hypothesis tests H1; :::; Hm are performed with independent test statis-
tics T1; :::; Tm. Let Hi = 0 when the null hypothesis i is true and Hi = 1 otherwise. It is
assumed that the test statistics under the true null Ti j(Hi = 0) and under the alternative
hypothesis Ti j(Hi = 1) are identically distributed. It is further assumed that the same rejec-
tion region is used for each test. Finally it is assumed, that the Hi are independent Bernoulli
random variables with P (Hi = 0) = 0 and P (Hi = 1) = 1 0 = 1. Let   be the common
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rejection region for each hypothesis test. Then the FDR can be written as:
FDR = P (H = 0 j T 2  ) = 0P (T 2   j H = 0)
0P (T 2   j H = 0) + 1P (T 2   j H = 1)
=
0P (T 2   j H = 0)
P (T 2  ) (2.3)
In the following hypotheses are rejected on the basis of independent p-values. For rejections
based on p-values, all rejection regions are of the form [0; ] for some   0. In terms of
p-values the above result can be written as:
FDR() =
0P (p   j H = 0)
P (p  ) =
0
P (p  ) (2.4)
where p is the random p-value resulting from any test.
Since 0 is an unknown parameter, it has to be estimated. Storey (2002) proposed the
following conservative estimate of 0:
^0() =
]fpi > g
(1  )m =
W ()
(1  )m (2.5)
for some well-chosen , where p1; :::; pm are the observed p-values, and W () = ]fpi > g is
the number of observed p-values exceeding . For a small proportion of null hypotheses this
estimator can be larger than 1, thus in this cases it is set to 1. The argument for the choice
of the estimator ^0() could be explained as follows: As long as each test has reasonable
power the large p-values are most likely to come from the true null hypothesis. Therefore
for a well chosen , it is expected, that 0(1   ) of the p-values lie in the interval (; 1],
because the p-values under the true null hypotheses are uniformly distributed. Therefore
W ()=m  0(1   ), where E[^0()]  0 when the p-values corresponding to the true
null hypotheses are uniformly distributed.
There is an inherent bias-variance trade oﬀ in the choice of . When  gets smaller, the bias
of ^0 gets larger, but the variance gets smaller. Choosing a larger  reduces the bias at the
cost of higher variance (Storey et al. (2004)). Therefore,  can be chosen to try to balance
this trade-oﬀ. Storey (2002) optimized the value for  to minimize the mean squared error
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of the estimate with bootstrap methods. However, simulations showed that when choosing
a non-optimal  the diﬀerence in their true mean-squared errors is not very drastic. For his
calculations he used  = 0:5.
It is now assumed that  is ﬁxed. An estimate of P (p  ) is:
P̂ (p  ) = ]fpi  g
m
=
R()
m
where R() = ]fpi  g. The estimate for the FDR is then given by:
̂FDR() = ^0()
P̂ (p  ) =
W ()
(1  )maxfR(); 1g (2.6)
If ̂FDR() > 1 Storey suggest setting ̂FDR() = 1.
Storey, Taylor and Siegmund (2004) proved that if the p-values corresponding to the true
null hypotheses are independent and uniformly distributed, then for ﬁxed  2 [0; 1):
E[ ̂FDR()]  FDR()
for all  and 0 < 1.
For the ﬁnite sample case, that means in the case of a small m, Storey et al. (2004) in-
troduced the following modiﬁcation ^0 of the estimator for 0:
^0() =
W () + 1
(1  )m (2.7)
for  2 [0; 1). Therefore, the estimate of FDR() for the ﬁnite sample case is:
̂FDR() =

^0()m
maxfR();1g , if   
1 , if  > 
(2.8)
Note that Storey (2002) ﬁxed a rejection boundary  and proposed an estimator for the FDR.
To perform a test controlling a pre-chosen FDR , the largest  has to be determined, such
that ̂FDR()  . For  = 0 Storey's procedure for a pre-chosen FDR is equivalent to the
Benjamini-Hochberg procedure. For  > 0, the rejection boundary  is larger compared to
the Bejamini-Hochberg method and thus it may be more powerful.
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3 Two-stage designs applying methods
diﬀering in costs
3.1 Introduction
In gene expression and proteomic studies we generally deal with large numbers of hypotheses,
where only for a small fraction of the hypotheses noticeable eﬀects exist. Due to limited
resources, the number of observations per hypothesis in a conventional single-stage design is
low which limits the power. It has been shown that two-stage (or multi-stage) designs are
a good option to improve the power. In these sequential designs, early stages are used to
screen for the promising hypotheses, which are further investigated in later stages.
Two common approaches of such two-stage designs can be found in the literature. In the
ﬁrst type the sample sizes for the ﬁrst and the second stage are preplanned. The second
stage data is only collected for the hypotheses selected after the ﬁrst stage and thus the
total number of observations across stages and hypotheses (e.g.: total costs or overall gene
evaluations) is random. Miller, Galecki and Shmookler-Reis (2001) suggested a two-stage
design which uses ﬁrst stage data only for the selection of hypotheses. After the second
stage the test decision was only based on the second stage data ("pilot design"). To control
the Family Wise Error Rate (FWER) a Bonferroni correction was performed for the second
stage test. Satagopan and Elston (2003) improved this procedure using a group sequential
approach (see also Jennison and Turnbull (2000)). Here the observations pooled over both
stages were used for the ﬁnal test ("integrated design"). Given a ﬁx overall sample size they
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focused on determining a two-stage design that minimizes the total cost of the study such
that the desired overall signiﬁcance level is controlled and the power is close to the desired
power of the corresponding single-stage approach.
Since the control of the FWER may lead to conservative procedures, Benjamini and Yekutieli
(2005) used the FDR concept for a two-stage procedure. In the ﬁrst stage they test the m
null hypotheses using the Benjamini-Hochberg procedure (see Section 2.3.1) for a prespec-
iﬁed level q1. In the second stage for the selected hypotheses again a Benjamini-Hochberg
procedure is used, now for a diﬀerent level q2 than in the ﬁrst stage. They proved that
if the test statistics are positively regression dependent on each hypothesis from the subset
corresponding to true null hypotheses and for q1 and q2 ﬁxed in advance, the FDR of their two-
stage procedure is less or equal to m0q1q2=m, where m0 is the number of true null hypotheses.
Van den Oord and Sullivan (2003) discussed the pilot and the integrated design control-
ling the FDR for more than two stages. Their general idea was that at earlier stages they
allow for a high FDR. Markers that very likely do not have real eﬀects are excluded from
further analysis. At a later stage it will be needed to specify a low FDR to reduce the false
discoveries. They minimized the overall observations for an intended power while controlling
a pre-speciﬁed level for the FDR. The pilot and integrated two-stage design were further
investigated in Bukszár and Van den Oord (2006).
In the second type of two-stage designs it is assumed, that there is a limitation on resources,
that means the overall number of observations is ﬁxed but not the overall sample size. A
certain fraction of these resources is spent in the ﬁrst stage for screening and the remaining
resources are used in the second stage. Since the number of selected hypotheses is random,
in this approach the second stage sample size is random. In the procedure of Satagopan,
Verbel, Venkatraman, Oﬃt and Begg (2002) the ﬁnal test is performed using the combined
subjects from both stages. A small preﬁxed number of hypotheses showing the highest test
statistics after the second stage test is rejected. Their aim was to maximize the power with
respect to the proportion of hypotheses selected for validation in the second stage and to
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the proportion of resources allocated for the ﬁrst stage. They showed that their procedure is
more powerful than a single-stage design. However, this procedure neither controls the FWER
nor the FDR. Instead of ﬁxing the total number of observations Satagopan, Venkatraman
and Begg (2004) ﬁxed the total number of sample size so that no sample-size reallocation
can be performed. They showed for the same procedure as in Satagopan et al. (2002) that
two-stage designs can produce a reduction in gene evaluations for a minimal loss of power as
compared to the single-stage design.
Zehetmayer, Bauer and Posch (2005) proposed (optimal) two-stage designs for experiments
with a large number of hypotheses and constraints on the total sample size which control the
FDR. All hypotheses whose conventional univariate ﬁrst stage p-values are below a certain
common threshold are selected for the second stage. The ﬁnal test decision is based on the
observations pooled over both stages. Zehetmayer et al. (2005) also investigated optimal
pilot designs where the ﬁnal test is only based on the second stage data (see also her doctoral
thesis: Zehetmayer (2006)). Pilot designs controlling the FWER are discussed in Ohashi and
Clark (2005). Further comparisons between the pilot and the integrated design can also be
seen in Skol, Skott, Abecasis and Boehnke (2006). Recently Zehetmayer, Bauer and Posch
(2008) have shown what can be achieved in terms of power by increasing the number of
stages when total costs are ﬁxed (see also their references to the literature on multi-stage
designs).
In all these proposals constant costs and eﬀect sizes over stages have been assumed.
In the following we investigate this type of two-stage designs where the costs per measure-
ment diﬀer between the ﬁrst and second stage (see also Wang, Thomas, Pe'er and Stram
(2006)). In modern genetic studies, there is an increasing focus on using a less accurate
assay in early stages and more accurate ones in later stages for cost reasons. For example, a
quasi-quantitative, global LC-MS proﬁling proteomics experiment may underestimate the true
eﬀect size due to saturation or sensitivity eﬀects inherent in these multiplexed assays, whereas
a targeted, calibrated assay (e.g. ELISA) can show an eﬀect size generally larger than the
proﬁling study. This work has been motivated by a study that aimed to deﬁne marker proﬁles
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to predict response to chemotherapy using a proteomic approach. A two-stage design was
planned to ﬁnd such predictors. Due to the shortage of resources a low-cost standard method
(2D Gelelectrophoresis) was applied at the ﬁrst stage to screen for possible predictors. At
the second stage a more expensive (and hopefully more eﬀective) method was planned to
be used for the promising predictors selected at the ﬁrst stage (Western Blot). It was to
expensive to apply the improved method for all patients and all proteins.
We consider two scenarios: In the ﬁrst scenario diﬀerent costs per measurement may arise
if the same method is applied at both stages but speciﬁc experimental devices have to be
produced at higher costs per measurement for the selected markers at the second stage, e.g.
special chips have to be produced. In contrast to Wang et al. (2006) who constructed designs
minimizing the overall costs for a given FWER and power, we assume that the total costs
of the experiment are ﬁxed, similar to Satagopan et al. (2002), Zehetmayer et al. (2005) or
Ohashi and Clark (2005). We further consider in a second scenario that the experimenter
from the beginning may have the choice between two methods that diﬀer in costs and eﬀect
sizes. For limited total costs we derive both integrated and pilot designs with an asymp-
totically optimal power (for an increasing number of null hypotheses), either controlling the
FWER or the FDR.
The test problem is deﬁned in Section 3.2, the corresponding single-stage procedures in
Section 3.3. In Sections 3.4 and 3.5 we deﬁne the asymptotically optimal pilot and inte-
grated design controlling the FWER or the FDR. In Section 3.6 we give examples for the ﬁrst
scenario, where the costs per observation diﬀer between stages, but the eﬀect size remains
the same. Scenario 1 is further investigated in Section 3.7 calculating cost ratios between
stages for which it is worthwhile to use (optimal) two-stage designs (see Section 3.7.1).
We further look how design misspeciﬁcations in the planning phase would change the power
of two-stage designs as compared to the standard single-stage design (Section 3.7.2). For
the second scenario we show that depending on the cost and the eﬀect ratios between the
methods it is preferable either to apply the low-cost or the high-cost method on both stages
(Section 3.8).
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Section 3.9 shows results under less stringent distributional assumptions like the situation
of unknown variances (Section 3.9.1) or correlated hypotheses (Section 3.9.2). Results for
the constraint of integer stage-wise sample sizes are given in Section 3.9.3. A discussion of
all results is given in Section 3.10.
3.2 Test problem
Consider m1 (null) hypotheses for the mean of independent normally distributed observations
with known variance:
H0i : i = 0 against H1i : i > 0, i = 1; :::; m1.
For deriving the test procedures, we assume independence of observations across hypotheses.
3.3 The single-stage design
We assume there is a limit for the overall total costs (resources) C of the study. Without loss
of generality the costs per observation of the single-stage design are set to 1. In the standard
single-stage design we equally allocate n = C=m1 observations to each of the m1 hypotheses.
The test statistics used for decisions are the p-values pi = 1 (zi), i = 1; :::; m1, where zi
is the standardized mean of the sample taken to test H0i and  is the distribution function of
the standard normal distribution. The p-values are compared to a common critical boundary
: If pi <  the null hypothesis H0i is rejected, otherwise it is accepted. We further assume
that for a fraction 0 of the m1 hypotheses considered the null hypothesis is true. To sim-
plify later calculations we also assume that the same mean i = ﬀ holds true for all the
alternatives, where ﬀ2 is the common known variance.
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To control the FWER (the probability to reject at least one true null hypothesis irrespective
of how many and which are in fact true, see Section 2.1) we apply the critical Bonferroni
boundary  = =m1 (see Section 2.2). The power of such a single-stage design is deﬁned by
∏
s
= 1  () = 1 √
C
m1
;1
(c1 );
where () denotes the Type II error as a function of the rejection boundary , ;ﬀ2 is the
distribution function of the normal distribution with mean  and variance ﬀ2, and c1  is
the (1  )-quantile of the standard normal distribution. Note that under the assumption of
a common alternative the power is the expected fraction of null hypotheses correctly rejected.
To control the FDR (the expected proportion of erroneous rejections among all rejections,
see Section 2.1) we apply the method of Storey (2002) estimating the FDR (see Section
2.3). The critical value  is then determined as the maximum such that
^0m1
max(]fpi < g; 1)  : (3.1)
Here ^0 is the estimated proportion of true null hypotheses given by
^0 = ]fpi > g=f(1  )m1g; (3.2)
where ; 0 <  < 1, is a constant chosen a priori and ]fpi > g denotes the number of p-
values exceeding . Hence the critical boundary is determined from the sample such that the
estimated FDR never exceeds the targeted value . Using the method of Storey the critical
boundary is a random variable. Asymptotically (for m1 !1 and C = dm1 for d > 0),  can
be determined from the equation
 =
0
0 + (1  0)(1  ()) : (3.3)
and plugged into the formula for
∏
s = (1  ()) to approximate the real power.
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3.4 The pilot design
3.4.1 The test procedure
We consider the same test problem as described in Section 3.2. Again we assume there is a
limit of overall total costs C for the study. Now a fraction r of the total costs C is used for
the ﬁrst stage for testing the m1 hypotheses. Thus, for balanced sample size allocation the
sample size of the ﬁrst stage per hypothesis is
n1 = rC=m1:
The ﬁrst stage p-values are given by p(1)i = 1 (z (1)i ) where z (1)i is the ﬁrst stage mean of
the observations for hypothesis H0i , i = 1; :::; m1, standardized by using the common known
ﬁrst stage standard deviation ﬀ1. All null hypotheses are selected, whose p-values fall below a
threshold 1 (p
(1)
i < 1). All others are accepted. Hence a random number of m2 hypotheses
is selected for the second stage.
Assume the sampling costs vary between the two stages due to producing speciﬁc experi-
mental devices or applying a high-cost method in the second stage, so that the total costs
are m1n1 +m2n2c2 = C for some constant c2  1. The remaining costs (1  r)C again are
equally allocated over the selected null hypotheses so that the second stage sample size n2
is given by
n2 =
C  m1n1
m2c2
=
(1  r)C
m2c2
:
Let z (2)i denote the mean of the second stage sample for hypothesis H0i , now standardized by
using the common known second stage standard deviation ﬀ2. Consequently p
(2)
i = 1 (z (2)i )
denotes the second stage p-value for the selected null hypothesis H0i . In the pilot design the
p-value used for decisions after the second stage is only calculated from the second stage
sample. A selected hypothesis H0i is rejected if the second stage p-value falls below the
boundary 2 (p
(2)
i < 2). Otherwise it is accepted.
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3.4.2 The pilot design controlling the FWER
To control the FWER we simply apply the Bonferroni method to determine the rejection
boundary for the second stage p-value p(2)i , but in contrast to the single-stage design, the
adjustment refers to the number of selected hypotheses m2:
2 = =m2:
Since m2 is independent of the second stage data, clearly this procedure controls the FWER
at the level .
We now will try to determine a 1 and r which maximizes the power of the two-stage design
controlling the FWER. We assume that at stage one for all alternative hypotheses the same
mean 1i = ﬀ1 and at stage two the same mean 2i = kﬀ2; k  1, holds true respectively.
The advantage when using an improved method as compared to using the low-cost standard
method is measured in terms of eﬀect size, i.e. there may be a larger mean or a smaller
variance when using the high-cost method. k is the ratio of the eﬀect sizes between the
two stages and we assume that the high-cost method at the second stage never provides a
smaller eﬀect size than the low-cost method at stage one. The ﬁrst stage power for a true
alternative is given by
1  1(1) = P1i=ﬀ1(p(1)i < 1) = 1 pn1;1(c1 1):
Note that under the assumption of a common alternative this is the expected proportion of
correctly selected null hypotheses among all null hypotheses for which the alternative holds.
For the second stage we select a number of m2 hypotheses which asymptotically is given
by
m2 = m1(1  0)(1  1(1)) +m101:
Because of the independence between the two stages, the overall power of the pilot design,
that is the expected fraction of null hypotheses correctly rejected after the second stage
among all null hypotheses for which the alternative holds, is asymptotically given by
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∏
p
= (1  1(1))(1  2(2))
= (1 pn1;1(c1 1))(1 pn2k;1(c1  m2 ))
= (1 √
rC
m1
;1
(c1 1))(1 √ (1 r)C
m2c2
k;1
(c1  
m2
)): (3.4)
Given a FWER , an initial number of hypotheses m1, overall costs C, the cost ratio c2
between stages, the proportion of true null hypotheses 0, the eﬀect size  and the eﬀect
size ratio k between stages we can optimize
∏
p in the two design parameters r and 1.
Considering r as an continuous variable the optimal sample sizes per stage (n1 and n2) in
general will be non-integer. The case of integer stage-wise sample sizes is discussed later in
Section 3.9.3. It is easy to see that the optimal 1 and r depend on C, m1,  and k via√
C
m1
 and k=
p
c2 and the critical boundary =m2.
3.4.3 The pilot design controlling the FDR
To control the False Discovery Rate the second stage critical boundary 2 is determined as
in formulas (3.1) and (3.2) replacing m1 by m2.
Asymptotically, for large m1, the ﬁrst stage selection boundary 1 and the second stage
rejection boundary 2 in the pilot design have to adhere to the equation
 =
021
021 + (1  0)(1  1(1))(1  2(2)) (3.5)
where (1  1(1))(1  2(2)) is the power ∏p of the pilot design deﬁned in (3.4) using 2
instead of =m2:
∏
p
= (1  1(1))(1  2(2))
= (1 √
rC
m1
;1
(c1 1))(1 √ (1 r)C
m2c2
k;1
(c1 2)): (3.6)
Again the power
∏
p can be optimized as function of r and 1, where 2 follows from condition
(3.5).
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3.5 The integrated design
3.5.1 The test procedure
We address the same test problem as in Section 3.2. The screening step of the test procedure
at the ﬁrst stage is identical to the pilot design in the previous Section 3.4. The only diﬀerence
to the pilot design is, that the ﬁnal test decisions based on the selected null hypotheses are
derived from integrated p-values pi = 1   (zi) which are based on the data from both
stages. An obvious way to construct single combination test statistics zi from both stages
is to combine the stage-wise standardized means by suitable weights as applied for adaptive
multi-stage clinical trials (see e.g. Lehmacher and Wassmer (1999)):
zi =
p
w1z
(1)
i +
√
1  w1z (2)i : (3.7)
Now the test decision is again very simple: A selected null hypothesis H0i is rejected in
the ﬁnal test if pi < . Otherwise it is accepted. Optimizing the non-centrality parameter
(
p
w1
p
n1 +
p
1  w1pn2k) of the test statistics zi leads to the optimal weight
w1 =
n1
n1 + n2k2
: (3.8)
If the same method (with the same eﬀect size, k = 1) is used at both stages then the weight
w1 = n1=(n1 + n2) corresponds to that used in a group sequential two-stage design. Note
that using non-optimal weights may lead to a larger power of the pilot design as compared
to the integrated design when the eﬀect size in the second stage is much larger than in the
ﬁrst stage (as already pointed at by Skol et al. (2006)).
3.5.2 The integrated design controlling the FWER
Assuming n2 as deterministic, the local level of the two-stage design  when controlling the
FWER is the solution of:
s = PH0i (p
(1)
i < 1; pi < ) =
∫ 1
c1 1
[
1 (c1   
p
w1zp
1  w1 )
]
'(z)dz (3.9)
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where s is set to =m1. ' denotes the density function of the standard normal distribution.
Note again that in the test procedure described, n2 is random because it depends on the
number of selected hypotheses (which also is random). It follows from the assumption of
independence of the observations across hypotheses, that the conditional distribution of n2,
given that the i-th hypothesis is selected, is independent of p(1)i . Thus the level (3.9) can be
also used for random n2.
By re-formulating the test decisions in terms of a sequential p-value psi based on the mono-
tonic ordering by Tsiatis, Rosner and Metha (1984) (H0i is rejected if psi < s) one can show
that the procedure mentioned above with the predeﬁned sample size reallocation rule for the
selected null hypotheses controls the FWER because under the null hypothesis they follow a
uniform distribution (see Zehetmayer et al. (2005)):
The overall p-value for a group sequential two-stage test based on a monotonic ordering
of the sample space as proposed in Tsiatis et al. (1984) is given by:
psi =

p
(1)
i if p
(1)
i > 1∫1
c1 1
[
1 ( zi 
p
w1zp
1 w1 )
]
'(z)dz else
(3.10)
(see Brannath, Bauer and Posch (2002)). The integral in (3.10) is the same as in (3.9)
with c1 2 replaced by the observed z-statistics in the total sample. With (3.9), every critical
region (p(1)i  1; pi  ) corresponds to a critical region (psi  s) and vice versa. The
p-value psi is uniformly distributed under the null hypothesis H0i . Thus, let s (0  s  1)
be ﬁxed and  the solution of (3.9), then
PH0i (psi  s) = PH0i (p(1)i  1; pi  ) = s :
The overall power of an integrated two-stage design is given by
∏
int
= P1i=ﬀ1;2i=kﬀ2(p
(1)
i < 1; pi < )
=
∫ 1
c1 1
[
1 pn2k;1(
c1   pw1zp
1  w1 )
]
'pn1;1(z)dz
=
∫ 1
c1 1
1 √
(1 r)C
m2c2
k;1
(
c1   pw1zp
1  w1 )
'√
rC
m1
;1
(z)dz; (3.11)
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where ';ﬀ2 is the density function of the normal distribution with mean  and variance ﬀ2.
Given the other quantities C, c2, m1, 0,  and k we can optimize
∏
int in the two design
parameters r and 1. Note that the optimal 1 and r , as in the pilot design, depend on C,
m1, , k and c2 via
√
C
m1
 and k=
p
c2 and the critical boundary =m1.
As mentioned above, using non-optimal weights for the test statistics (3.7) leads to a larger
power of the pilot design as compared to the integrated design when k is large. Figure 3.1
shows the asymptotic optimal power for varying k for the pilot design and the integrated
design with and without optimal weights (see formula (3.8)). We consider the example of
m1 = 1000 hypothesis tests. A fraction of 0 = 0:99 true null hypotheses and an eﬀect size
in the ﬁrst stage of  = 0:5 is assumed. Overall total costs are set to C = 20000 and the
cost ratio is set to c2 = 15. The targeted FWER is  = 0:05. Figure 3.1 shows that whereas
the integrated design with optimal weights with increasing k has a slightly larger power than
the pilot design, the integrated design using non-optimal weights show a considerable loss
of power as compared to the other two designs. For small k both integrated designs show
Figure 3.1: Asymptotically optimal power of the pilot design (dotted line) and the integrated
design with (dashed line) and without (solid line) optimal weights for control of
the FWER ( = 0:05) for varying k :
C = 20000, m1 = 1000, c2 = 15, 0 = 0:99,  = 0:5.
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nearly the same power and thus the power of both integrated designs is slightly larger then
the power of the pilot design. For k = 1 the power values of the integrated designs with and
without optimal weights are clearly the same. Further examples for the integrated design and
the pilot design are considered later in Section 3.6.
3.5.3 The integrated design controlling the FDR
For the control of the False Discovery Rate, asymptotically the rejection boundary for the
p-values in the ﬁnal test is given by the solution of
 =
0s
0s + (1  0)(1  (s)) (3.12)
where s is a function of  which is given by (3.9). Such a two-stage procedure with a pre-
deﬁned sample size allocation rule controls the FDR since it can be shown that the resulting
sequential p-values psi are independent across hypotheses (see Zehetmayer et al. (2005))
such that the results of Storey (2002) on the consistency and conservativeness of the esti-
mator of the FDR apply.
Again optimal values of r and 1 can be determined by maximizing the power (3.11) un-
der the constraint (3.12). The rejection boundary  for the p-values pi of the selected null
hypotheses, calculated from pooling stage-wise z-scores (3.7) with optimal weights (3.8),
then can be found numerically from solving equation (3.9).
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3.6 Examples: optimal designs for k = 1 and c2  1
Asymptotically optimal two-stage designs applying the same method at both stages (k = 1)
can be also derived in Zehetmayer et al. (2005) if the costs do not diﬀer between stages
(c2 = 1) using appropriately deﬁned total costs C. In the following we focus on designs using
the same method at both stages, the second stage measurement however raising extra costs
c2 > 1. When c2 > 1 we have to use the power formulas (3.4) (and (3.6) respectively when
controlling the FDR) and (3.11) with k = 1 to derive asymptotically optimal designs.
Table 3.1 and 3.2 for k = 1 and some c2 give the design parameters of optimal pilot and
integrated designs and their power for controlling the FWER (Table 3.1) and the FDR (Table
3.2). Note that the optimal power values given for the integrated designs are only slightly
larger than those of the pilot designs and both two-stage designs controlling the FDR have
only a slightly larger power than when controlling the FWER. For comparison the power values
of the (asymptotic) single-stage designs with equal total costs for the control of the FWER
and FDR are listed in Table 3.3. As compared to the corresponding single-stage designs, the
power of the two-stage designs is always considerably larger, even in the case of c2 = 15.
As one can see from the tables, the asymptotic optimal screening boundary 1 decreases
with increasing costs c2 for the whole designs considered (pilot or integrated design control-
ling the FWER or FDR). For the same costs the screening boundary 1 slightly increases with
increasing . At the same time the proportion of costs used for the ﬁrst stage r increases
with . Note that due to the complexity of the power function there is a diﬀerent dependence
of r on costs for low and large eﬀect sizes, which is also depending on FDR or FWER control.
At least the asymptotically optimal number of selected hypotheses m2 increases with  and
decreases with costs c2 throughout the whole designs considered. The decrease of m2 with
increasing costs may be a consequence of the decreasing screening boundary 1.
Table 3.4 shows the asymptotic optimal design parameters for diﬀerent values of the propor-
tion of true null hypotheses 0 for the case of c2 = 15 and  = 0:75. For increasing 0, the
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optimal fraction of total costs used in the ﬁrst stage r is increasing, i.e. if the number of
alternatives gets smaller, more costs and thus more sample size is needed in the ﬁrst stage
for screening to achieve the optimal power. There is a diﬀerent dependence on the design
used (pilot or integrated) and on FDR or FWER control for 1. With increasing 0, the
asymptotic optimal power is increasing and m2 is decreasing .
Table 3.1: Optimal two-stage designs controlling the FWER ( = 0:05).
Asymptotically optimal parameters 1, r and the power (
∏
p or
∏
int) as well as the
second stage rejection boundary (2 or ) and m2 for diﬀerent c2 and . k = 1,
C = 20000, m1 = 1000, 0 = 0:99.
 c2 Design r 1
∏
p or
∏
int 2 or  m2
0.5 1 pilot 0.635 0.07398 0.594 0.00063 79.55
integrated 0.642 0.07665 0.603 0.00010 82.31
5 pilot 0.683 0.01544 0.341 0.00262 19.06
integrated 0.697 0.01599 0.351 0.00017 19.74
15 pilot 0.685 0.00563 0.214 0.00621 8.04
integrated 0.706 0.00611 0.226 0.00023 8.68
0.75 1 pilot 0.718 0.09209 0.926 0.00050 100.51
integrated 0.725 0.10262 0.934 0.00006 111.03
5 pilot 0.737 0.01870 0.762 0.00190 26.38
integrated 0.759 0.02060 0.783 0.00009 28.50
15 pilot 0.701 0.00686 0.589 0.00381 13.13
integrated 0.745 0.00733 0.628 0.00010 14.03
1 1 pilot 0.774 0.09684 0.995 0.00047 105.83
integrated 0.779 0.12025 0.997 0.00005 129.02
5 pilot 0.781 0.01931 0.966 0.00173 28.82
integrated 0.806 0.02368 0.974 0.00006 33.23
15 pilot 0.722 0.00713 0.893 0.00309 16.17
integrated 0.787 0.00825 0.925 0.00007 17.58
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Table 3.2: Optimal two-stage designs controlling the FDR ( = 0:05).
Asymptotically optimal parameters 1, r and the power (
∏
p or
∏
int) as well as the
second stage rejection boundary (2 or ) and m2 for diﬀerent c2 and . k = 1,
C = 20000, m1 = 1000, 0 = 0:99.
 c2 Design r 1
∏
p or
∏
int 2 or  m2
0.5 1 pilot 0.632 0.09571 0.641 0.00356 101.57
integrated 0.639 0.10070 0.651 0.00063 106.64
5 pilot 0.701 0.01915 0.379 0.01053 23.17
integrated 0.707 0.02024 0.387 0.00062 24.37
15 pilot 0.716 0.00671 0.242 0.01922 9.44
integrated 0.723 0.00707 0.249 0.00053 9.91
0.75 1 pilot 0.715 0.11907 0.943 0.00421 127.39
integrated 0.722 0.13734 0.951 0.00063 145.57
5 pilot 0.765 0.02455 0.810 0.01754 32.64
integrated 0.778 0.02873 0.828 0.00069 37.00
15 pilot 0.766 0.00871 0.673 0.04104 15.74
integrated 0.788 0.01045 0.700 0.00064 17.82
1 1 pilot 0.772 0.12115 0.997 0.00437 129.91
integrated 0.776 0.15811 0.998 0.00058 166.52
5 pilot 0.807 0.02459 0.977 0.02111 34.15
integrated 0.824 0.03296 0.983 0.00065 42.50
15 pilot 0.799 0.00859 0.936 0.05793 17.97
integrated 0.832 0.01209 0.954 0.00066 21.63
Table 3.3: Single-stage designs controlling the FWER and FDR ( = 0:05).
Power
∏
s for diﬀerent . C = 20000, m1 = 1000 and 0 = 0:99.
 FWE-Control FDR-Control
0.5 0.049 0.056
0.75 0.296 0.443
1 0.720 0.877
30
3.6 Examples: optimal designs for k = 1 and c2  1
Table 3.4: Optimal two-stage designs for diﬀerent 0.
Asymptotically optimal parameters 1, r and the power (
∏
p or
∏
int) as well as the
second stage rejection boundary (2 or ) and m2 for diﬀerent 0 for FWER or
FDR Control:  = 0:75, c2 = 15 k = 1, C = 20000, m1 = 1000.
0 Design r 1
∏
p or
∏
int 2 or  m2
FWER 0.985 pilot 0.653 0.00680 0.543 0.00320 15.65
integrated 0.718 0.00709 0.593 0.00010 16.75
0.99 pilot 0.701 0.00686 0.589 0.00381 13.13
integrated 0.745 0.00733 0.628 0.00010 14.03
0.995 pilot 0.759 0.00676 0.641 0.00495 10.07
integrated 0.784 0.00747 0.668 0.00010 10.95
FDR 0.985 pilot 0.753 0.00676 0.662 0.05895 19.46
integrated 0.783 0.01104 0.694 0.00090 22.14
0.99 pilot 0.766 0.00900 0.673 0.04104 15.74
integrated 0.788 0.01045 0.700 0.00064 17.82
0.995 pilot 0.788 0.00871 0.684 0.02258 11.55
integrated 0.800 0.00934 0.704 0.00035 13.01
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3.7 When to use two-stage designs
3.7.1 Break even point in the cost-ratio
It has been shown that for large m1 and constraints on the total costs the power of an
asymptotic optimal two-stage design (see Tables 3.1 and 3.2) may be considerably larger
than the power of the corresponding single-stage design (Table 3.3). Again the scenario is
considered where the same method is applied at the two stages (k = 1) and the second stage
measurement raises extra costs (c2 > 1).
We investigate when it is more eﬃcient in terms of asymptotic power to use a two-stage
design as compared to the single-stage design, i.e. we tackle the problem by asking whether
a cost ratio c2 exists, where the power of the single-stage and the two-stage design are the
same. If the asymptotic power would be monotonically decreasing in c2 for c2 > c2 the
single-stage design would provide a larger power than the two-stage design.
The ﬁrst important answer is that for the integrated design such a ﬁnite c2 does not ex-
ist, because for given C, m1, , k and  and c2 ! 1 the power of the asymptotic optimal
integrated design converges to the power of the single-stage design applying the low-cost
measurement method ( lim
c2!1
r = 1). Hence for the integrated approach theoretically the
two-stage approach always pays oﬀ. However in practice, if the optimal second stage sample
size gets too small, the two-stage design cannot be used.
For the pilot design the power converges to 0 as c2 ! 1. Hence for the pilot design in
general such a break even point c2 between the two-stage and single-stage design exists.
Figure 3.2 shows the power values of the integrated and the pilot design as well as the power
of the single-stage design controlling the FWER or the FDR for varying c2.
Figure 3.3 shows c2 for varying 0 and  for the case of controlling the FWER or the
FDR at  = 0:05. Again C is set to 20000 and m1 is set to 1000. The curves are fairly sim-
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ilar for control of the FWER and the FDR, the break even point varying more when the FDR
is controlled. For large eﬀect sizes, the power of the single-stage design and the pilot design
are close to 1, and consequently c2 is small. For decreasing eﬀect sizes the break even point
c2 is increasing. When the number of true alternatives decreases (0 increases) c

2 increases.
In both situations a smaller number of null hypotheses is selected for the second stage (with
larger sample sizes n2) so that we can aﬀord higher costs for the selected hypotheses. Note
that the power when controlling the FDR is always slightly larger than when controlling the
FWER. If there is a relatively large proportion of alternatives with substantial eﬀects, the
break even point is smaller for controlling the FDR than the FWER: the single-stage design
controlling the FDR then is noticeably more powerful than the single-stage design controlling
the FWER. For decreasing  this advantage in power of the single-stage FDR design over
the single-stage FWER design decreases whereas the optimal two-stage design controlling
the FDR still has favorable properties as compared to the two-stage FWER design. Hence
larger second stage costs can be aﬀorded to achieve the same power as the corresponding
single-stage design. This may lead to a crossing of the two corresponding curves. For ex-
planation see also Figures 3.4, which show the power values of the pilot design for diﬀerent
c2 as well as the power of the corresponding single-stage design assuming 0 = 0:99 (Figure
(A)) and 0 = 0:995 (Figure (B)).
For the example of  = 0:75, the break even point is at c2 = 81:38 for FWER and at
c2 = 76:89 for FDR control assuming 0 = 0:99, that means if c2 > 81:38 (76:89), the
single-stage power is larger than the two-stage power (see Figure 3.3). Hence the two-
stage design is preferable even if the cost ratio between stages is fairly high. Assuming
0 = 0:985, the break even point is at c2 = 57:63 (FWER) and c

2 = 45:68 (FDR) and
assuming 0 = 0:995 at c2 = 141:36 (FWER) and c

2 = 168:69 (FDR). For 0 = 0:985 and
0:99 the break even point when controlling the FWER is larger than when controlling the
FDR. For 0 = 0:995 the breakeven point controlling the FDR is larger.
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Figure 3.2: Power values for the integrated (dotdashed lines) and the pilot design (dashed
lines) as well as the single-stage design (solid lines) controlling the FWER (thin
lines) or FDR (bold lines) for varying cost ratio c2. C = 20000, m1 = 1000,
 = 0:75, 0 = 0:99, FWER and FDR both  = 0:05.
Figure 3.3: Break even point c2 for the cost ratio between the asymptotically optimal pilot
design and the single-stage design depending on  and 0, for controlling the
FDR (dashed lines) or the FWER (solid lines).
C = 20000, m1 = 1000, FWER and FDR both  = 0:05.
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Figure 3.4: Power for the pilot design controlling the FWER (thin dashed lines) or FDR (bold
dashed lines) as well as for the single-stage design (FWER: thin solid line, FDR:
bold solid line) for diﬀerent c2 and  for 0 = 0:99 (Figure (A)) and 0 = 0:995
(Figure (B)). C = 20000, m1 = 1000, FWER and FDR both  = 0:05.
3.7.2 Impact of design misspeciﬁcations
Whereas costs are usually known a priori, the optimal designs depend on the unknown propor-
tion of true null hypotheses 0 and eﬀect size . Hence the impact of design misspeciﬁcations
in the planning phase is an important issue.
We want to investigate the question whether there is an amount of misspeciﬁcation where it
would have been better to use a single-stage design. That means, whether we can misspecify
the design parameters in that way, that the single-stage design would have a larger power
than the two-stage approach. In the following again we consider the situation of C = 20000,
m1 = 1000 and  = 0:05. It is assumed that the optimal r and 1 were planned for the
situation where  = 0:75, 0 = 0:99 and k = 1. Figures 3.5 show the diﬀerences between
the power of the two-stage designs and the corresponding single-stage designs as a function
of the true 0 and  for controlling the FDR and FWER for the example of c2 = 1 and
Figures 3.6 for c2 = 15 (confer Wang et al. (2006)). Positive values indicate superiority of
the two-stage design. The cross marks the point for which the two-stage design parameters
were planned.
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Figure 3.5 shows that assuming the same costs per observation in both stages (cost ra-
tio c2 = 1), for the shown parameter subspace for the true 0 and , the single-stage design
neither outperforms the pilot design (ﬁrst row of panels) nor the integrated design (second
row) controlling the FWER (ﬁrst column) or FDR (second column). One can also see from
the ﬁgures, that the integrated design is more robust against misspeciﬁcation of the design
parameters than the pilot design. Note that for the pilot design such region, where it would
have been better to perform a single-stage design exists, but only for severe design misspec-
iﬁcations (outside the parameter subspace shown). The power of the integrated design for
c2 = 1 is always larger or equal to the power of the single-stage design.
The example of ﬁxing the cost ratio c2 = 15 is plotted in Figure 3.6, again for the pilot
(ﬁrst row) and the integrated design (second row). Not surprising, the ﬁgures show that
again the integrated design is more robust against misspeciﬁcations of 0 and  than the
pilot design: it uses the whole data set from both stages for test decisions. The most robust
design is the integrated design controlling the FWER (Figure 3.6 (C)). Here in the parameter
subspace shown the two-stage integrated design is always noticeably better than the single-
stage design. Controlling the FDR, the advantage of the single-stage design to adapt for 0
results in smaller diﬀerences between the integrated two-stage design and the single-stage
design (Figure 3.6 (D)): in the left upper corner the single-stage design is outperforming the
two-stage design. The bold line mark equality between the single-stage and the two-stage
design.
The pilot design controlling the FWER is more sensible with regard to the design misspeciﬁ-
cations than the pilot design controlling the FDR. The design applies "non-optimal" selection
criteria and controlling the FWER no adaption to the correct parameters is possible in the
second stage sample (Figure 3.6 (A)): in the left upper corner the power of the single-stage
design may become substantially larger than the two-stage pilot design. Controlling the FDR
adapting to the true parameters in the second stage sample helps a little (Figure 3.6 (B)):
there is only a slightly larger power of the single-stage design as compared to the two-stage
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pilot design in the left upper corner. Figures 3.7 show the power values for the pilot, the
integrated and the single-stage design for control of the FWER (ﬁrst column) or the FDR
(second column), assuming that only one design parameter is misspeciﬁed, either  (ﬁrst
row) or 0 (second row).
Generally, a design optimal for a fraction of true null hypotheses which is larger than the
true 0 can lead to a considerable loss of power as compared to the corresponding single-
stage design. However, if the true 0 gets larger than the proportion used for planning and
the true eﬀect size  is close to the one used for planning generally the diﬀerence between
two-stage designs and the single-stage design increases. Optimism in the planning phase with
regard to the number of true alternatives may help to avoid a loss of power due to design
misspeciﬁcation. If the true eﬀect size  gets larger than the one from the planning phase
for values of 0 close to the true one the power of the two-stage and single-stage design
both approach 1 so that the diﬀerences in the contour plots decrease.
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Figure 3.5: Contour plots for the diﬀerence in power between the single-stage and the pilot
design (ﬁrst row) and the single-stage and the integrated design (second row)
as a function of the true 0 and  for controlling the FWER (ﬁrst column) or
the FDR (second column). Positive values indicate superiority of the two-stage
design. Asymptotically optimal two-stage designs were planned for 0 = 0:99
and  = 0:75 (marked as cross, confer Tables 3.1, 3.2 and 3.3).
C = 20000, c2 = 1 and m1 = 1000, FWER and FDR both  = 0:05.
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Figure 3.6: Contour plots for the diﬀerence in power between the single-stage and the pilot
design (ﬁrst row) and the single-stage and the integrated design (second row)
as a function of the true 0 and  for controlling the FWER (ﬁrst column) or
the FDR (second column). Positive values indicate superiority of the two-stage
design. Bold lines mark equality between the single-stage and the two-stage
design. Asymptotically optimal two-stage designs were planned for 0 = 0:99
and  = 0:75 (marked as cross, confer Tables 3.1, 3.2 and 3.3).
C = 20000, c2 = 15 and m1 = 1000, FWER and FDR both  = 0:05.
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Figure 3.7: Power of the pilot design (solid lines), the integrated design (dashed lines) for
c2 = 1 and c2 = 15 and the corresponding single-stage design (dotdashed lines)
for varying true  (ﬁrst row) and true 0 (second row) controlling the FWER
(ﬁrst column) or the FDR (second column). Asymptotically optimal two-stage
designs were planned for 0 = 0:99 and  = 0:75.
C = 20000 and m1 = 1000, FWER and FDR both  = 0:05.
40
3.8 Comparison of two-stage procedures
3.8 Comparison of two-stage procedures
3.8.1 Two-stage procedures using the pilot design
We now assume that the experimenter has two diﬀerent candidate methods for the mea-
surements from the very beginning, a low-cost standard method and a high-cost improved
method. So he could apply the same method at both stages (low-low or high-high) or he
may switch to the more expensive method at the second stage (low-high).
In the following we investigate which of these three procedures is more powerful when con-
trolling the FWER or the FDR. The power of the pilot design controlling the FWER for the
low-high procedure is given by (3.4). Clearly the power of a procedure using the low-cost
method in both stages,
∏
pl l
, say, is given by setting k = 1 and c2 = 1 (see also Zehetmayer
et al. (2005)):
∏
pl l
= (1 √
rC
m1
;1
(c1 1))(1 √ (1 r)C
m2
;1
(c1  
m2
)): (3.13)
The power for the procedure using the high-cost method at both stages,
∏
phh
, say, arises from
(3.4) by using (1   √
rC
m1c2
k;1
(c1 1)) for the ﬁrst stage power leaving the second stage
power unchanged:
∏
phh
= (1 √
rC
m1c2
k;1
(c1 1))(1 √ (1 r)C
m2c2
k;1
(c1  
m2
)): (3.14)
It is easy to see that for k =
p
c2 we get the identity
∏
p 
∏
pl l
 ∏phh . Hence the maxima
of all three functions in r and 1 are identical.
Since the power formulas for the three procedures are monotonic in c2, the two-stage pro-
cedure applying the low-cost measurement method at both stages dominates the other two
procedures (low-high and high-high) if the high-cost method is not suﬃciently eﬃcient, i.e.,
when c2 > k2. For c2 < k2 the high-high procedure dominates the other two. Hence the
conclusion is that the procedure switching from the low-cost to the high-cost method is never
the best procedure in terms of asymptotic power. However, it may be useful if the asymptot-
ically optimal sample size at the ﬁrst stage n1 is too small for the high-high procedure, e.g.
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in case of lack of ﬁnance so that the high-high procedure cannot be applied in the ﬁrst stage.
Figures 3.8 show the maximum asymptotically optimal power over the three procedures for
the pilot design (ﬁrst row) for varying c2, given the constraint n1  1 (Figure 3.8 (A)) and
n1  2 (Figure 3.8 (B)) for the control of the FWER. Two diﬀerent eﬀect size ratios are as-
sumed, k = 3 and 4. The example C = 20000, m1 = 1000, 0 = 0:99 and  = 0:05 (FWER)
is considered assuming an eﬀect size for the low-cost measurement method of  = 0:5. Thus
the eﬀect sizes of the high-cost method are assumed to be 1:5 and 2. The asymptotically
optimal power is given for the three procedures (low-low: dotdashed line, low-high: dashed
line, high-high: dotted line). The solid lines mark the respective maximal power over the three
procedures if at least one (Figure 3.8 (A)) or if at least two (Figure 3.8 (B)) observations
are left at the ﬁrst stage for the optimal high-high procedure. Note that for the other two
procedures the asymptotically optimal n1 for the investigated values of c2 is always larger than
two. The power of the low-low procedure for the pilot design controlling the FWER is al-
ways
∏
pl l
= 0:594 since it does not depend on c2 (compare also Table 3.1 in the Section 3.6).
Obviously the high-high procedure has the maximum power for relatively low costs c2. For
the cost ratio k = 4 the solid curve jumps when the costs of the high-cost method gets too
large resulting in an asymptotic optimal n1 < 1. This jump occurs at c2 = 13:11 (Figure 3.8
(A)). Note that the crossing point with the low-low procedure is at c2 = 16. Here the region
where the low-high procedure is preferable to both the other is very small, for k = 3 no such
region exists. If we apply the constraint n1  2, the region where the low-high procedure is
preferable gets larger, the jump between the high-high and the low-high procedure occurs at
c2 = 7:17 (Figure 3.8 (B)). For our example such a region does also exist for an eﬀect ratio
of k = 3, where the jump between the high-high and low-high procedure is at c2 = 6:66. The
common crossing point between the three procedures for k = 3 is at c2 = 9.
For the control of the FDR the power of the pilot design for the low-high procedure (see
formula (3.6)) has to be modiﬁed in the same way as for FWER control. Thus, the power
for the low-low and the high-high procedure can be achieved by replacing =m2 in formulas
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(3.13) and (3.14) by 2. Hence there is the same common crossing point for FDR control.
Figures 3.9 (A) and (B) show the three procedures for the pilot design controlling the FDR.
The ﬁgures look similar to them controlling the FWER. Note that the power for the low-low
pilot procedure is always
∏
pl l
= 0:641 (compare Table 3.2 in Section 3.6). The jump between
the high-high and low-high design is at c2 = 13:06 for k = 4 under the constraint n1  1
and at c2 = 7:15 for k = 4 and c2 = 6:64 for k = 3 under the constraint n1  2. The area,
where the low-high design is preferable, is only slightly larger for FDR control.
Note that in our example the high-cost method is much more eﬀective than the low-cost
method. If we have only double eﬀects for the expensive method than the low-low procedure
would be already preferable if the costs are only four times larger. Hence if the improved
method is much more expensive it has to be much more eﬀective to apply a high-high or a
low-high procedure. Note also that the crossing point depends on the unknown eﬀect size
and no procedure dominates the other two over the whole parameter space. Hence in case
of design misspeciﬁcations in the planning phase there will be other parameter constellations
where the low-high type of strategy is in fact more powerful. However when no misspeciﬁ-
cations occur, the low-high procedure may only be preferable if the high-cost method is too
expensive so that the ﬁrst stage sample size for the high-high procedure is insuﬃciently small.
In genomic or proteomic studies frequently there is no possibility for a low-low design, since
methods for investigating selected hypotheses are more expensive than screening methods.
For example the 2D-Gelelectrophoresis may be a good option for screening but it can not
focus on special proteins so that no sample size reallocation can be performed. Thus it cannot
be used in a second stage of a two-stage design. Therefore one may need a more improved
method, like e.g. the Westernplot, which further investigates the 2D-Gelelektrophoresis. If
it is not possible to use the low-low procedure, the low-high procedure may be a good option
for a larger range of cost ratios c2. As compared to the single-stage design, either using
the high-cost method or using the low-cost method, the maximum over the three two-stage
procedures for c2 > 1 is larger, for small c2 only slightly larger. For c2 = 1 the power values
of the high-cost single-stage design, the low-high and the high-high procedure in our example
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are equal to one. Note that for the low-high pilot design for c2 = 1 the optimal 1 = 1
and the optimal r = 0 and thus the optimal low-high pilot design is equal to the high-cost
single-stage design. Figures 3.10 show again the optimal power of the three two-stage pro-
cedures for the pilot designs and additionally the power of the single-stage design using the
high-cost method or using the low-cost method controlling the FWER (Figure (A)) and the
FDR (Figure (B)) for varying c2  2. Whereas the power of the low-cost single-stage design
is always small, the power of the high-cost single-stage design for small c2 is similar to those
from the low-high procedure, and thus, larger than the power of the low-low procedure. For
increasing c2 the high-cost single-stage design considerably looses power and for large c2 it
falls below the power of the low-cost single-stage design.
When an experimenter from the beginning may have the choice between a low-cost and
a high-cost method, there is also a fourth possibility of a two-stage procedure not mentioned
above, to screen with the high-cost method and investigate the selected hypotheses with the
low-cost method. In the genomic or proteomic studies, this combination in most cases does
not make sense. As mentioned above, the methods that are able to look at selected hy-
potheses are often the expensive, improved methods and the low-cost methods are preferable
for screening. Thus the high-low procedure often is not possible to apply. Nevertheless, we
had a look at this combination for the two-stage procedures controlling the FWER. Figure
3.11 (A) again shows the asymptotically optimal power of the low-low, the low-high and the
high-high procedure for varying c2 and additionally the power of the high-low procedure is
given. The solid line shows the maximal power over the four designs under the constraint of
n2  2 for the high-high and the high-low procedure. The area, were the high-low procedure
is preferable is strikingly small. Applying the high-low design the optimal n1 for the screening
step is only slightly larger than applying the high-high design. Since we use the high-cost
method in both designs for screening similar ﬁrst stage sample sizes are needed. However,
a much smaller m2 is selected for the second stage leading to a much larger n2 when using
the low-cost method in the second stage. Assuming an eﬀect size ratio of k = 4, this area
is between c2 = 7:17 and c2 = 7:36 and assuming an eﬀect size ratio of k = 3 the high-low
procedure is preferable if 6:66  c2  6:77.
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3.8.2 Two-stage procedures using the integrated design
Comparing the three procedures for the integrated design we have to modify the formula
for the power
∏
int given for the low-high procedure in (3.11). For the low-low procedure to
calculate the power we have to insert k = 1 and c2 = 1 (see Zehetmayer et al. (2005)):
∏
intl l
=
∫ 1
c1 1
1 √
(1 r)C
m2
;1
(
c1   pw1zp
1  w1 )
'√
rC
m1
;1
(z)dz: (3.15)
For the high-high procedure we have to replace
p
n1 by
√
n1
c2
k:
∏
inthh
=
∫ 1
c1 1
1 √
(1 r)C
c2m2
k;1
(
c1   pw1zp
1  w1 )
'√
rC
c2m1
k;1
(z)dz: (3.16)
It can be seen easily that again for k =
p
c2 the three power functions are identical so that
there is the same crossing point for the integrated design. Essentially the results are very
similar to those for the pilot design (see Figure 3.8 (C) and (D) for the control of the FWER
and Figure 3.9 (C) and (D) for the FDR control). Controlling the FDR the modiﬁcation of
the power formula is similar.
For k = 4 the jump between the high-high design and the low-high design under the con-
straint n1  1 occurs at c2 = 13:18 when controlling the FDR and c2 = 13:24 for FWER
control. No such jump exists for k = 3. Under the constraint n1  2 for k = 4, this jump
is at c2 = 7:20 for FDR and at c2 = 7:24 for FWER control. For k = 3, the jump occurs
at c2 = 6:70 for FDR and c2 = 6:73 for FWER control. Note that the power of the low-low
procedure is always 0:651 for FDR and 0:603 for FWER control (again compare Tables 3.1
and 3.2). The area where the low-high procedure is preferable, is slightly smaller as compared
to the pilot design. Again, as compared to the two possible single-stage designs, as in the
pilot design, the maximum over the three two-stage procedures is always larger.
Note that the common crossing point only exists if in the integrated low-high procedure
the optimal weights (3.8) are used for combining the stage-wise test statistics. The low-high
procedure loses power when applying non-optimal weights.
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We also investigated the high-low procedure for the integrated design controlling the FWER
under the constraint n1  2 (see Figure 3.11 (B)). The results are similar to the pilot design.
The area where this procedure is preferable is again very small, but slightly larger than for
the pilot design. For k = 4 this procedure is preferable if 7:24  c2  7:47 and for k = 3 if
6:73  c2  6:84.
Figure 3.8: Asymptotically optimal power of the low-low (dotdashed horizontal line), the
low-high (dashed lines) and the high-high (dotted lines) procedure of the pilot
design (ﬁrst row) and the integrated design (second row) controlling the FWER
( = 0:05) for varying c2 and eﬀect size ratios k = 3 and k = 4. The solid lines
mark the respective maximum over the three procedures under the constraint
n1  1 (ﬁrst column) and n1  2 (second column) for the high-high procedure.
C = 20000, m1 = 1000, 0 = 0:99,  = 0:5.
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Figure 3.9: Asymptotically optimal power of the low-low (dotdashed horizontal line), the low-
high (dashed lines) and the high-high (dotted lines) procedure of the pilot design
(ﬁrst row) and the integrated design (second row) controlling the FDR ( = 0:05)
for varying c2 and eﬀect size ratios k = 3 and k = 4. The solid lines mark the
respective maximum over the three procedures under the constraint n1  1 (ﬁrst
column) and n1  2 (second column) for the high-high procedure.
C = 20000, m1 = 1000, 0 = 0:99,  = 0:5.
47
3 Two-stage designs applying methods diﬀering in costs
Figure 3.10: Asymptotically optimal power of the low-low (dotdashed horizontal line), the
low-high (dashed lines), the high-high (dotted lines) as well as the single-stage
design using the high-cost (bold dotted line) or the low-cost method (bold dot-
dashed line) for the pilot design controlling the FWER (Figure (A)) and the
FDR (Figure (B))for varying c2. k = 4, C = 20000, m1 = 1000, 0 = 0:99,
 = 0:5, FWER and FDR both  = 0:05.
Figure 3.11: Asymptotically optimal power of the low-low (dotdashed horizontal line), the
low-high (dashed lines), the high-high (dotted lines) and the high-low (dotdot-
dashed lines) procedure of the pilot design (Figure (A)) and the integrated design
(Figure (B)) controlling the FWER ( = 0:05) for varying c2 and eﬀect size
ratios k = 3 and k = 4. The solid lines mark the respective maximum over the
four procedures under the constraint n1  2 for the high-high and the high-low
procedure. C = 20000, m1 = 1000, 0 = 0:99,  = 0:5.
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3.9 Extensions
3.9.1 The situation of unknown variances
To investigate the situation of unknown variances we performed optimizations for the pilot
design. Because of the independence between the ﬁrst and the second stage, the pilot design
can be easily applied to the unknown variance case by using the central and non-central t-
distributions instead of the corresponding normal distributions. Thus, the power of the pilot
design controlling the FWER for the unknown variance case is given by:
∏t
p
= (1  F√
rC
m1
;n1 1
(c t1 1;n1 1))(1  F√ (1 r)C
m2c2
k;n2 1
(c t1  
m2
;n2 1)); (3.17)
where F;n is the distribution function of the non-central t-distribution with non-centrality
parameter  and n degrees of freedom and c t1 1;n is the (1   1)-quantile of the central
t-distribution with n degrees of freedom. The Power
∏t
p can now, as in the known variance
case, be optimized as function of r and 1 for a given FWER , an initial number of hypothe-
ses m1, overall costs C, a cost ratio c2, a proportion of true null hypotheses 0, an eﬀect
size  and an eﬀect size ratio k .
For the control of the FDR the power of the pilot design for the unknown variance case
can also be easily applied by replacing =m2 in formula (3.17) by 2:
∏t
p
= (1  F√
rC
m1
;n1 1
(c t1 1;n1 1))(1  F√ (1 r)C
m2c2
k;n2 1
(c t1 2;n2 1)): (3.18)
Asymptotically (for m1 !1 and C = dm1 for d > 0), the second stage rejection boundary
2 have to adhere to the equation
 =
021
021 + (1  0)∏tp : (3.19)
Again the power
∏t
p calculated with formula (3.18) can be optimized as function of r and 1
where 2 follows from condition (3.19).
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Table 3.5: Optimal pilot designs controlling the FWER or FDR ( = 0:05) for the un-
known variance case.
Asymptotically optimal parameters 1, r as well as the number of selected hy-
potheses m2 and the power using the optimal parameters from the unknown (
∏t
p)
and the known variance case (
∏t
p ) for diﬀerent c2 and . The power values
∏
s
of the corresponding single stage designs are given.
k = 1, C = 20000, m1 = 1000, 0 = 0:99.
 c2 r 1 m2
∏t
p
∏t
p
∏
s
FWER 0.5 1 0.622 0.075 80.53 0.555 0.555 0.020
5 0.681 0.016 19.08 0.283 0.282
15 0.692 0.006 7.97 0.162 0.160
0.75 1 0.696 0.094 102.34 0.905 0.903 0.122
5 0.722 0.020 26.79 0.681 0.680
15 0.702 0.007 12.48 0.473 0.471
1 1 0.747 0.100 109.15 0.992 0.991 0.391
5 0.755 0.021 30.48 0.932 0.931
15 0.709 0.008 16.10 0.791 0.791
FDR 0.5 1 0.618 0.097 102.77 0.608 0.608 0.039
5 0.695 0.020 22.92 0.318 0.318
15 0.718 0.007 8.82 0.180 0.180
0.75 1 0.694 0.123 130.70 0.930 0.929 0.159
5 0.748 0.026 33.88 0.747 0.746
15 0.757 0.009 15.52 0.565 0.564
1 1 0.747 0.127 135.64 0.995 0.995 0.660
5 0.784 0.028 37.28 0.957 0.957
15 0.783 0.010 19.08 0.877 0.875
Table 3.5 shows the optimal parameters r and 1 for the pilot design for the unknown variance
case controlling the FWER or FDR for diﬀerent cost ratios c2 and eﬀect sizes . The eﬀect
size ratio between stages k was set to 1. Again the example of C = 20000, m1 = 1000
and 0 = 0:99 is considered. The optimal power values using the optimal parameters for
the unknown variance case (
∏t
p) are shown. For comparison to the known variance case see
Tables 3.1 and 3.2. The optimal power values in the unknown variance case clearly decrease
as compared to the power values for the known variance case. The number of the selected
hypotheses m2, like in the known variance case, decreases with increasing c2 and increases
with increasing . As compared to the known variance case always a smaller m2 is selected
for the second stage through the whole examples considered.
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Table 3.5 also shows the power
∏t
p using the optimal parameters from the known variance
case. It can be seen that using the parameters of the known variance case in the situation of
unknown variances leads to virtually the same performance as using the optimal parameters
from the unknown variance case.
The impact of misspeciﬁcation is investigated in Figures 3.12. Contour plots for the dif-
ference in power between the single-stage and the pilot design as a function of the true 0
and  for controlling the FWER (ﬁrst row) or the FDR (second row) for c2 = 1 (ﬁrst column)
and c2 = 15 (second column) are shown. Positive values indicate superiority of the two-stage
design. Again the example of C = 20000 and m1 = 1000 is investigated. Asymptotically
optimal two-stage designs were planned for 0 = 0:99 and  = 0:75 (marked as cross, confer
Table 3.5). The results are similar to the known variance case, for comparison see Figures
3.5 and 3.6. Assuming a cost ratio of c2 = 1, in the parameter space shown, the single-
stage design is not outperforming the pilot design (Figures (A) and (B)). For c2 = 15 the
single-stage design, as in the known variance case, in the left upper corner is outperforming
the pilot design (Figures (C) and (D)).
Finally we will have a look at Scenario 2 for the unknown variance case. The decision which of
the three two-stage procedures (low-low, high-high, low-high) is preferable, is more diﬃcult
because no common crossing point in costs as a function of c2 between the three procedures
exists. However, the region where the low-high procedure is preferable still remains small.
Figures 3.13 shows the asymptotically optimal power for the unknown variance case of the
low-low (dotdashed horizontal line), the low-high (dashed lines) and the high-high (dotted
lines) procedure of the pilot design controlling the FWER (Figure 3.13 (A)) and the FDR
(Figure 3.13 (B)) ( = 0:05) for varying c2 and eﬀect size ratios k = 3 and k = 4. The solid
lines mark the respective maximum over the three procedures for the high-high design. Note
that in the unknown variance case we need anyway n1  2 in order to be able to estimate
the variance.
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For FWER control (Figure 3.13 (A)) the crossing point between the high-high and the low-
high design is at c2 = 6:05 for k = 4 and at c2 = 4:82 for k = 3. The corresponding
asymptotic optimal ﬁrst stage sample sizes n1 for the high-high design at those crossing
points are 2:29 for k = 4 and 2:75 for k = 3. The crossing point between the low-high
design and the low-low design is c2 = 9:02 for k = 4 and at c2 = 6:31 for k = 3. Note that
the power of the low-low design controlling the FWER is always 0:555 (see Table 3.5).
For FDR control the results are similar (see Figure 3.13 (B)). The crossing point between
the high-high and the low-high design is at c2 = 6:39 for k = 4 and at c2 = 5:06 for k = 3.
The corresponding n1 for the high-high design at the crossing points are 2:14 for k = 4 and
2:58 for k = 3. The crossing point between the low-high design and the low-low design is
c2 = 9:25 for k = 4 and at c2 = 6:44 for k = 3. The power of the low-low design controlling
the FDR is 0:608 for all values of c2 (see Table 3.5).
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Figure 3.12: Unknown variance case: Contour plots for the diﬀerence in power between the
single-stage and the pilot design as a function of the true 0 and  for controlling
the FWER (ﬁrst row) or the FDR (second row) for c2 = 1 (ﬁrst column) and
c2 = 15 (second column). Positive values indicate superiority of the two-stage
design. Asymptotically optimal two-stage designs were planned for 0 = 0:99
and  = 0:75 (marked as cross, confer Table 3.5).
C = 20000, m1 = 1000, FWER and FDR both  = 0:05.
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Figure 3.13: Unknown variance case: Asymptotically optimal power for the unknown variance
case of the low-low (dotdashed horizontal line), the low-high (dashed lines) and
the high-high (dotted lines) procedure of the pilot design controlling the FWER
(A) and the FDR (B) for varying c2 and eﬀect size ratios k = 3 and k = 4.
The solid lines mark the respective maximum over the three procedures for the
high-high design. C = 20000, m1 = 1000, 0 = 0:99,  = 0:5, FWER and
FDR both  = 0:05.
3.9.2 Correlated hypotheses
To investigate the impact of correlation we assume an autoregressive correlation structure
among the hypotheses. The correlation between hypothesis i and j is given by ji j j for some
 2 (0; 1). The alternative hypotheses are randomly distributed among the m1 = 1000 hy-
potheses. The eﬀect size for the alternatives is assumed to be  = 0:75 and the proportion
of true null hypotheses 0 = 0:99. We considered the situations of c2 = 1; 5 and 15 assum-
ing  = 0:2; 0:6 and 0:9 for the pilot design controlling the FWER and FDR by simulation.
The total costs C were again set to 20000. Asymptotically optimal parameters 1 and r of
the uncorrelated case are used (compare Tables 3.1 and 3.2) for the simulations (100000
simulated samples).
The results for FWER control are shown in Table 3.6. The selection boundary increases with
increasing correlation whereas the power decreases with increasing correlation. Since we use
the Bonforroni correction, the FWER is controlled despite the correlation structure. It is
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Table 3.6: Simulation for the pilot design controlling the FWER ( = 0:05) assuming
correlated hypotheses (100000 simulation steps).
Simulation results (
∏s
p, 
s
2, and 
s) under the constraint of autocorrelated hy-
potheses for diﬀerent c2 and . Asymptotically optimal parameters 1 and r of
the uncorrelated case were used (compare Tables 3.1 and 3.2).
 = 0:75, k = 1, C = 20000, m1 = 1000, 0 = 0:99.
 c2
∏s
p (SD) 
s
2 (SD) 
s ms2 (SD)
0.2 1 0.923 (0.084) 0.00050 (0.00005) 0.044 100.54 (10.00)
5 0.753 (0.133) 0.00196 (0.00037) 0.035 26.39 ( 4.64)
15 0.574 (0.145) 0.00404 (0.00108) 0.025 13.14 ( 3.07)
0.6 1 0.921 (0.086) 0.00051 (0.00007) 0.042 100.52 (13.96)
5 0.747 (0.137) 0.00200 (0.00047) 0.033 26.37 ( 5.84)
15 0.571 (0.149) 0.00414 (0.00131) 0.024 13.12 ( 3.59)
0.9 1 0.909 (0.099) 0.00054 (0.00018) 0.030 100.26 (28.49)
5 0.728 (0.160) 0.00228 (0.00109) 0.022 26.42 (11.19)
15 0.556 (0.174) 0.00478 (0.00256) 0.015 13.12 ( 6.34)
interesting to see that the FWER decreases with increasing correlation and with increasing
c2. With increasing c2 less hypotheses are selected for the second stage and thus, less true
null hypotheses. Hence the FWER level cannot be fully exploited.
Simulation results (
∏s
p, 
s
2, 
s and ms2) under the constraint of autocorrelated hypothe-
ses for the control of the FDR are shown in Table 3.7. As for the FWER control, the
power decreases and the selection boundary increases with increasing correlation. It has to
be mentioned that for large costs the number m2 of selected hypotheses may become small,
so that the ﬁnite sample size modiﬁcation proposed by Storey et al. (2004) has to be used in
order to guarantee control of the FDR. Simulation results using the common estimator (^0)
or the ﬁnite sample estimator (^0) are given. Using the ﬁnite sample estimator leads to a
slight decrease in power. However, for large correlation ( = 0:9) the average FDR over the
simulated samples is larger than the targeted level of  = 0:05. For  = 0:6 the ﬁnite sample
modiﬁcation helps to control the FDR. The FDR is increasing with increasing correlation.
Figures 3.14 and 3.15 show boxplots of the actual FDR for the 100000 simulated sam-
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Table 3.7: Simulation for the pilot design controlling the FDR ( = 0:05) assuming
correlated hypotheses (100000 simulation steps).
Simulation results (
∏s
p, 
s
2, m
s
2 and 
s) under the constraint of autocorrelated
hypotheses for diﬀerent c2 and . Simulation results using the common estimator
(^0) or the ﬁnite sample estimator (^0) are given. Asymptotically optimal param-
eters 1 and r of the uncorrelated case were used (compare Tables 3.1 and 3.2).
 = 0:75, k = 1, C = 20000, m1 = 1000, 0 = 0:99.
 c2
∏s
p (Sd) 
s
2 (SD) 
s (SD) ms2 (SD)
0.2 1 ^0 0.941 (0.076) 0.00430 (0.00082) 0.048 (0.067) 127.37 (11.23)
^0 0.941 (0.076) 0.00423 (0.00079) 0.047 (0.067) 127.35 (11.19)
5 ^0 0.802 (0.130) 0.01973 (0.01104) 0.052 (0.077) 32.65 ( 5.25)
^0 0.800 (0.131) 0.01767 (0.00755) 0.047 (0.073) 32.65 ( 5.25)
15 ^0 0.659 (0.158) 0.07111 (0.12176) 0.064 (0.102) 15.74 ( 3.34)
^0 0.649 (0.160) 0.04145 (0.03323) 0.046 (0.081) 15.72 ( 3.34)
0.6 1 ^0 0.939 (0.077) 0.00438 (0.00106) 0.049 (0.072) 127.93 (15.93)
^0 0.939 (0.077) 0.00429 (0.00102) 0.048 (0.071) 127.40 (15.96)
5 ^0 0.798 (0.134) 0.02114 (0.01628) 0.054 (0.084) 32.65 ( 6.75)
^0 0.796 (0.134) 0.01857 (0.01043) 0.049 (0.079) 32.65 ( 6.72)
15 ^0 0.654 (0.164) 0.08635 (0.16059) 0.068 (0.111) 15.76 ( 3.98)
^0 0.646 (0.166) 0.04453 (0.03985) 0.047 (0.087) 15.75 ( 3.96)
0.9 1 ^0 0.930 (0.089) 0.00505 (0.00399) 0.052 (0.110) 127.52 (32.81)
^0 0.930 (0.089) 0.00054 (0.00312) 0.051 (0.107) 127.32 (32.98)
5 ^0 0.777 (0.164) 0.05276 (0.13547) 0.074 (0.148) 32.61 (13.16)
^0 0.774 (0.164) 0.03116 (0.04876) 0.062 (0.131) 32.60 (13.11)
15 ^0 0.634 (0.197) 0.23403 (0.35788) 0.089 (0.161) 15.73 ( 7.17)
^0 0.626 (0.198) 0.07240 (0.07949) 0.057 (0.130) 15.75 ( 7.22)
ples for the pilot design under the constraint of correlated hypotheses for varying c2 and 
using the common and the ﬁnite sample estimator.
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Figure 3.14: Boxplots of the actual FDR for the 100000 simulated samples for the pilot
design under the constraint of correlated hypotheses for varying c2 and  using
the common estimator for ^0.  = 0:75, k = 1, C = 20000, m1 = 1000,
0 = 0:99, targeted  = 0:05.
Figure 3.15: Boxplots of the actual FDR for the 100000 simulated samples for the pilot
design under the constraint of correlated hypotheses for varying c2 and  using
the ﬁnite sample estimator ^0.  = 0:75, k = 1, C = 20000, m1 = 1000,
0 = 0:99, targeted  = 0:05.
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3.9.3 Integer stage-wise sample sizes
In the examples investigated, we considered r as continuous variable and thus the optimal
sample sizes per stage (n1 and n2) in general will be non-integer. Since in reality we need
integer sample sizes, we performed simulations for the pilot design using the optimal r and
1 from the non-integer optimization. The situations from Tables 3.1 and 3.2 for  = 0:75
are investigated by simulation.
In order to achieve constant costs we ﬁrst rounded the non-integer ﬁrst stage costs rC
downwards and the second stage costs (1  r)C upwards. For the ﬁrst stage sample sizes we
used bbrCc=m1c + 1 for brCc mod m1 randomly chosen hypotheses and bbrCc=m1c for the
rest. For the second stage sample sizes we performed similar: we used bd(1 r)Ce=(m2c2)c+1
for d(1  r)Ce mod m2c2 randomly chosen hypotheses and bd(1  r)Ce=(m2c2)c for the rest.
bxc denotes the largest integer not exceeding x and dxe the smallest integer exceeding x .
Note that the simulated C may be slightly smaller than the targeted C = 20000.
Using designs with stage-wise integer sample sizes does not noticeable decrease the power as
compared to the optimal non-integer designs (see Tables 3.1 and 3.2). Table 3.8 gives the
results for the simulations under the constraint of integer stage-wise sample sizes for diﬀerent
c2 for the control of the FWER or FDR. Results for using the ﬁnite sample size modiﬁcation
to guarantee control of the FDR are given. Using this modiﬁcation leads to a slight decrease
in power. Table 3.8 shows simulation results for the control of the FDR using the common
estimator (^0) and using the ﬁnite sample estimator (^0). Using the common estimator for
c2 = 5; 15 the mean FDR (over the simulated samples) is larger than the targeted FDR of
0:05. Using the ﬁnite sample modiﬁcation in average the FDR is controlled. Figure 3.16
shows the Boxplots of the actual FDR for the 100000 simulated samples for the pilot design
under the constraint of integer stage-wise sample sizes for varying c2 using the common (ﬁrst
3 boxplots) and the ﬁnite sample estimator (last 3 boxplots).
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Table 3.8: Simulation results for the pilot design controlling the FWER or FDR ( =
0:05) under the constraint of integer stage-wise sample sizes (100000 simu-
lation steps).
Simulation results (
∏s
p, 
s
2, m
s
2 and 
s) under the constraint of integer stage-wise
sample sizes for diﬀerent c2. For the FDR control, simulation results using the
common estimator for 0 (^0) and using the ﬁnite sample modiﬁcation (^0) are
given. Asymptotically optimal parameters 1 and r using non-integer sample sizes
were used (Tables 3.1 and 3.2).
 = 0:75, k = 1, C = 20000, m1 = 1000, 0 = 0:99.
c2
∏s
p (Std) 
s
2 (Std) 
s m2 (Std)
FWER 1 0.924 (0.084) 0.00050 (0.00005) 0.044 100.54 ( 9.15)
5 0.753 (0.133) 0.00195 (0.00035) 0.034 26.38 ( 4.44)
15 0.574 (0.146) 0.00403 (0.00107) 0.025 13.14 ( 3.02)
FDR ^0 1 0.941 (0.075) 0.00433 (0.00076) 0.047 (0.067) 127.41 (10.20)
^0 0.941 (0.075) 0.00422 (0.00076) 0.047 (0.077) 127.44 (10.24)
^0 5 0.802 (0.129) 0.01970 (0.01105) 0.052 (0.103) 32.65 ( 5.02)
^0 0.800 (0.130) 0.01758 (0.00750) 0.047 (0.066) 32.66 ( 5.01)
^0 15 0.660 (0.157) 0.07028 (0.11881) 0.065 (0.072) 17.73 ( 3.25)
^0 0.649 (0.160) 0.04098 (0.03244) 0.045 (0.081) 15.73 ( 3.26)
Figure 3.16: Boxplots of the actual FDR for the 100000 simulated samples for the pilot design
under the constraint of integer stage-wise sample sizes for varying c2 using the
common (ﬁrst 3 boxplots) and the ﬁnite sample estimator (last 3 boxplots) for
0.  = 0:75, k = 1, C = 20000, m1 = 1000, 0 = 0:99, targeted  = 0:05.
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3.10 Discussion
We have investigated two-stage designs in the situation that large numbers of null hypothe-
ses are tested and only a small proportion of them are expected to be wrong. Moreover it
was assumed that there are constraints on total costs of the experiment. The ﬁrst stage
is used for screening out promising hypotheses which are then investigated further at the
second stage. We focussed on an important scenario in practice assuming that costs per
measurement diﬀer between stages: On the one hand extra costs may arise when the same
measurements have to be designed for a subset of hypotheses selected in an interim analysis
and investigated at the second stage. On the other hand the investigator from the very
beginning may have the choice between a low-cost method and a high-cost method, which
hopefully is more eﬃcient in terms of the eﬀect size under the alternatives. Given a large
number of candidate hypotheses we derived asymptotically optimal designs in terms of power
using the simplifying assumptions of common alternatives (either controlling the FWER or
the FDR).
We would like to summarize the results in the following way:
Two-stage screening designs are a very powerful tool even if we deal with equal eﬀect sizes at
the second stage but the costs for designing the measurements for the selected hypotheses
at the second stage are fairly high. Only severe design misspeciﬁcations in the planning phase
may lead to a noticeable loss of power such that the single-stage design may become superior
in power. With regard to the impact of design misspeciﬁcations in the proportion of true
alternatives it seems to be preferable not to assume too small proportions in the planning
phase. Integrated designs which use data from both stages for the ﬁnal test decisions are
more robust against design misspeciﬁcations.
If two diﬀerent methods are available, depending on the ratios between costs and eﬀect
sizes it is preferable to run two-stage designs which apply either the low-cost or the high-cost
method at both stages. Designs starting with the low-cost method and switching to the more
expensive method in the interim analysis may only be advisable if there is lack of resources
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so that ﬁrst stage sample size for the high-cost method would be too small. However, it has
to be kept in mind that the best design depends on the relationship of the eﬀect size and
the cost ratios. Hence in case of a eﬀect size misspeciﬁcations in the planning phase the
low-high method may actually be more powerful than the low-low or the high-high strategy.
However it seems natural to apply a design which is preferable under the parametric constella-
tion considered in the planning phase. In the integrated design the optimal way of combining
more over data from both stages arising from diﬀerent measurement methods depends on
the eﬀect size ratio between stages, which introduces a further complication for appropriately
designing such experiments applying diﬀerent methods.
With respect to deviations from the underlying assumption we calculated optimal designs
for the unknown variance case. The results for r and 1 are very close to those of the known
variance case. The optimal power decreases as compared to the known variance case. How-
ever, using the optimal parameters for the known variance case in the situation of unknown
variances leads to virtually the same performance as using the optimal parameters from the
unknown variance case. Concerning the second scenario, the decision which of the procedures
(low-low, high-high or low-high) is preferable is more diﬃcult because no common crossing
point in costs as a function of c2 between the three procedures exists. However, the region
where the low-high procedure is preferable still remains small.
To investigate the impact of correlation we assumed an autoregressive correlation struc-
ture among the hypotheses. The alternative hypotheses were randomly distributed among
the hypotheses. The impact of correlation was small like in the case of constant costs in
Zehetmayer et al. (2005). For the two-sided situation we refer to their proposal to test a set
of 2m1 one-sided hypotheses.
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4 Prognostic scores based on gene
expression or proteomic data
4.1 Introduction
When a large number of markers have to be investigated, we usually can not trust that a
few of these markers show big eﬀects. Instead we may hope that there is a combination of
several markers which, e.g., allow a prediction of the response of an individual patient to a
particular therapy. The task of selecting useful markers with rather moderate eﬀects from a
(very) large number of candidates and estimating suitable scores to be used for the prediction
in future patients is a formidable exercise. Moreover, due to limited resources generally small
sample sizes per marker are available which makes the problem even less tractable. It seems
that for a lot of medical research reported in this ﬁeld there has been insuﬃcient awareness
of the statistical properties of the resulting prognostic scores. Ntzani and Ioannidis (2003)
showed for prediction of cancer outcome that the constructed scores are poorly performing
in external validation samples. The better performance in a few small studies may also be
due to publication bias.
Subset selection procedures (e.g. Shao (1993), Miller (2002)) are widely used in this ﬁeld.
However, there is a general problem of how to quantify the probability for falsely selecting
ineﬀective parameters. There have been proposals of estimating the positive false discov-
ery rate in case that a nonzero model has been selected (Li and Hui (2007)). It is known
that model selection by multiple testing of individual model parameters under fairly general
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conditions asymptotically is a consistent selection procedure: for increasing sample size the
critical boundary for the individual test statistics (the parameter estimate divided by its stan-
dard error) has to approach inﬁnity at a smaller order than the inverse of the standard error
(see Bauer, Pötscher and Hackl (1988)). Asymptotic relationships between model selection
procedures and multiple tests controlling the False Discovery Rate (FDR, see Section 2.1)
have been shown (Abramovich, Benjamini, Donoho and Johnstone (2006)). However these
are general results which do not help how to choose the selection boundaries in a speciﬁc
sample.
In the following this problem of constructing prognostic scores is discussed. The multiple
testing type methods of selecting markers and constructing a linear prognostic score are con-
sidered in terms of the statistical properties of the resulting receiver operating characteristic
(ROC-curve) in future patients, e.g., in terms of how well they can predict the outcome
of a medical therapy in future patients. Various measures have been proposed to capture
discrimination, but the area under the ROC-curve (AUC) is the most popular quantity (see
e.g. Pencina et al. (2008)). It is a measure of the predictive ability of a score if the score is
used for diﬀerent thresholds with varying values of sensitivity and speciﬁcity. Note that the
AUC can be interpreted as the probability that in a randomly selected (according to a uniform
distribution) pair of responders and non-responders, the score value of the non-responder is
smaller than the score value of the responder.
For diﬀerent scenarios we assume that in the population a set of markers exists which, if
known, would lead to a prediction score with a ROC-curve crossing a benchmark point with
pre-ﬁxed benchmark values for sensitivity and speciﬁcity.
We discuss three selection methods:
 multiple testing of individual hypotheses controlling the FDR,
 using a stepwise selection procedure by testing individual parameters and
 selecting the k "best" markers in an unprotected way.
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Simulations for independent normal distributions with known variance will be presented for
a varying number of tested markers, varying sample sizes and varying proportion of eﬀective
markers with equal eﬀect sizes. To achieve a standardization, the eﬀect sizes are chosen such
that the optimal linear prediction of future patients, if known, would lead to an ROC-curve
crossing through the benchmark point where sensitivity and speciﬁcity are equal 0:9, thus the
theoretically achievable area under the ROC-curve (AUC) is 0:965. Finally the situation is
considered that cross validation is used to determine decision boundaries for the test based
selection procedure optimal with regard to the AUC, thus achieving some information on the
extent of false positive decisions.
Section 4.2 describes the investigated problem. In Section 4.3 the three selection meth-
ods are discussed and in Section 4.4 we explain the prediction scores based on these selection
methods. The results of the performed simulations can be seen in Section 4.6. Using cross
validation to determine decision boundaries is discussed in Section 4.7. In Section 4.8 we
investigate simulations assuming a smaller best theoretically achievable AUC, further on de-
noted by AUC, of 0:8. A short discussion of all results is given in Section 4.9.
4.2 The problem
Consider the following simple scenario: we want to search for predictors of a speciﬁc clinical
outcome (e.g. eﬀectiveness of certain chemotherapy) among a large set of m markers. Inde-
pendent samples of patients responding (nr) and non-responding (nnr) to a speciﬁc therapy
are available. Based on the marker values in responding and non-responding patients eﬀective
markers have to be selected and a score to predict response to therapy of future patients has
to be estimated. This type of situation may be encountered in many other areas of research
based on clinical data looked at together with gene expression or proteomic data.
Assume that the marker levels follow normal distributions with common known variance
ﬀ2 = 1 with means r;i , i = 1; :::; m, for responders and means nr;i , i = 1; :::; m, for non-
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responders.
In the following we will ﬁrst investigate selection procedures in a single training sample which
apply at least also for individual steps in model selection procedures, e.g. with cross validation
(considered later).
4.3 Selection of markers
We investigate three methods for the selection of promising predictors for a clinical outcome
of a future patient.
4.3.1 The protected approach based on a multiple test controlling the
false discovery rate
For the selection of prognostic markers for the prediction score we test the following set of
one sided null hypotheses:
H0i : r;i   nr;i = 0 against H1i : r;i   nr;i > 0, for i = 1; : : : ; m.
The standardized mean diﬀerences between responders and non-responders
zi = (xr;i   xnr;i)=
√
2=n; i = 1; : : : ; m
are calculated, where for simplicity we assume equal sample sizes per marker and group
n = nr;i = nnr;i for i = 1; : : : ; m. Test decisions are based on the one sided p-values
pi = 1 (zi), where  denotes the cumulative distribution function of the standard normal
distribution. To adjust for multiplicity, i.e. not to include too many nuisance markers without
any predictive ability in the score, we use Storey's approach (see Storey (2002)) to control
the FDR discussed in Section 2.3.2 (see Formula (2.6)) where the critical boundary  is es-
timated from the sample. Note that this method adapts to the estimated proportion of true
null hypotheses. The markers whose p-values fall below the critical boundary  are selected
to build a score in order to predict whether a future patient will respond or not respond to
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the treatment.
Note that for the two-sided p-values (pi = 1   (jzi j)) the same procedure applying the
critical boundary 
2
leads to the same results as the one-sided test under the global null
hypotheses. If under the alternative we assume constant eﬀect size among the eﬀective
markers (as in the following) the two-sided tests lead to the same results if the eﬀect size
is increased by (c1  
2
  c1 )=
√
n
2
where c1  denotes the (1   )-quantile of the standard
normal distribution (ignoring directional errors under the alternative).
4.3.2 Selection using stepwise forward logistic regression
Whereas the ﬁrst approach is only based on individual selection criteria for the markers, here
we use a multiple logistic regression approach with stepwise forward selection to assess the
contribution of the individual markers to predict response to therapy in the training sample.
We again use a ﬁxed threshold  for the p-values, this time calculated from the ﬁnal model
evolving in the multivariate logistic regression. The selection is done in such a way that
selected markers can again be removed from the model when their p-values in the aggregated
model fall above the threshold . The stepwise procedure ends with a ﬁnal model when
further markers fail to meet the selection criterion.
4.3.3 The optimistic approach by selecting the k best markers
Alternatively to the FDR-controlled approach, believing in the eﬀect of some of the markers,
simply the best k genes are selected for prediction. I.e., the genes with the k smallest
individual one-sided p-values are used to predict the clinical outcome of an independent future
patient.
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4.4 Prediction of the clinical outcome
After selecting k hypotheses by one of the three methods described we simply use a linear
combination of the selected markers as a prognostic score. Exploiting the assumptions of
independence across the markers and known variances, we simply use the linear score which
would be the Bayes solution for a given (unselected) set of k prognostic variables which
follow independent and identical normal distributions with unknown means and known variance
ﬀ2 = 1 (e.g. see Anderson (2003)):
f^ (x) = (^r   ^nr)Tx =
k∑
i=1
(xr;i   xnr;i)xi : (4.1)
Here to simplify notation we have rearranged the markers so that without loss of generality
^
T
r = (xr;1; :::; xr;k) and ^
T
nr = (xnr;1; :::; xnr;k) are the means of the k selected markers in the
training samples of the patients responding and not responding to therapy respectively and
x = (x1; :::; xk) are the values of the corresponding markers in a future patient (bold symbols
give vectors). If f^ (x) > c we predict a response, otherwise a non-response. The predic-
tive ability of such a score is assessed by the ROC curve resulting from varying threshold
values for the score, where sensitivity (for response) is plotted against (1-speciﬁcity) as a
function of c. Since we are interested in ROC curves the following results are invariant to
any strictly monotonic transformation of this score. Note that this discriminant analysis type
of predictors assuming diagonal covariance matrix is often also applied as an approximation
if correlations between the markers can not be excluded and under the known variance as-
sumption corresponds to the naive Bayes predictor.
In case of forward selection we simply use the estimated linear predictor for the log odds
from the ﬁnal model in the stepwise multiple logistic regression, which is of the same form
as (4.1) but uses the parameter estimates from the model instead of the diﬀerence in the
sample means of the selected markers. The score (4.1) is also used for the k selected best
markers in the optimistic approach.
Given the estimates from the training samples the prognostic score (4.1) follows a normal
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distribution:
N[f ; ﬀ
2
f ] = N[(^r   ^nr)T; (^r   ^nr)T (^r   ^nr)] (4.2)
where T = (1; : : : ; k) is the true mean vector of the k selected markers in an independent
future patient. Fixing  it is easy to get the ROC-curve for future independent populations
of responders and non-responders by calculating
Sensitiv ity = v = 1 f ;ﬀ2f (c
) = 1 (c
   f
ﬀf
)
and
Specif icity = 1  w = 0;ﬀ2
f
(c) = (
c
ﬀf
)
where ;ﬀ2 denotes the cumulative distribution function of the normal distribution with mean
value  and variance ﬀ2. Thus, the AUC can be calculated as:
AUC =
∫ 1
0
(1 (c1 w   f
ﬀf
))dw: (4.3)
Note that given the training samples the vector  depends on the selection procedure and
may also contain means from selected ineﬀective markers not contributing to prognosis.
4.5 Minimal eﬀect size 
To simplify the problem we assume that the eﬀective markers have a common mean r;i = r ,
i 2 E in the responding patients and a common mean nr;i = nr , i 2 E in the non-responding
patients, E denoting the index set of the me = jEj eﬀective markers among the m candi-
dates. For the non-eﬀective markers without loss of generality the mean diﬀerence between
responders and non-responders is assumed to be zero, r;j   nr;j = 0, j 2 (1; 2; ::; m) n E.
Hence for the eﬀective markers a common eﬀect size r nr =  is assumed to hold. In this
scenario a linear function of the values of the eﬀective markers (with equal weights) would
be the optimal score for prediction.
To get a benchmark let us assume that this optimal linear score built from the me eﬀec-
tive markers among the set of m markers is known. We now will ask, depending on the
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number me of eﬀective markers, what minimal common eﬀect size  is required to achieve
a ROC-curve crossing through the point where both sensitivity (v) and speciﬁcity (1   w)
have a certain pre-speciﬁed values, e.g., v = 1 w = 0:9? Clearly we get the best prognostic
score if all me eﬀective markers and no non-eﬀective markers are selected, and the true eﬀect
size  is known:
f (x) = (^r   ^nr)Tx = Tx = mei=1xi ;
which follows a normal distribution with:
N[f ; ﬀ
2
f ] = N[
T
;T] = N[me
2; me
2]
Hence the sensitivity for the theoretically best score for a future patient can be easily calcu-
lated as follows:
v = 1 (c1 w   me
2
p
me2
) = 1 (c1 w  
p
me)
and thus the eﬀect size required to cross the point (v ; 1  w) can be calculated as:
 =
c1 w   c1 vp
me
(4.4)
Figure 4.1 shows the minimal eﬀect size  depending on the number of eﬀective markers me
if the ROC-curve crosses the point v = 1 w = 0:9. Two examples are marked which will be
considered more closely in the simulation studies. For me = 60 an eﬀect size of  = 0:33 is
required to achieve such an ROC-curve. For me = 10 an eﬀect size of  = 0:81 is needed to
get a ROC-curve with such a property. Note that if there is only a single eﬀective marker an
eﬀect size of  = 2:56 is required. This demonstrates the crucial problem for gene expression
studies. If 60 eﬃcient markers work together they may show a large common eﬀect even if
there are only marginal individual eﬀect sizes. Thus, the process of selection of such markers
with only marginal eﬀects among a large number of candidates in relatively small samples will
be a formidable task. However, in case of a single or few eﬃcient markers the eﬀect size to
achieve good prognostic properties has to be pretty large, so that already small samples may
be suﬃcient to select those very inﬂuential markers.
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Figure 4.2 shows the minimal eﬀect size  required for the ROC-curve to cross through
the points v = 1   w = 0:9, 0:8 and 0:7 as a function of me. Clearly, to obtain a smaller
sensitivity and speciﬁcity smaller eﬀect sizes are required. E.g. to achieve a ROC-curve
crossing through the point v = 1  w = 0:8 an eﬀect size of  = 0:53 is needed if me = 10
and a very small  of 0:22 if me = 60.
Figure 4.1: Dependence of  on me: Minimal eﬀect size required for the ROC to cross
through the point where sensitivity and speciﬁcity are equal to 0:9 for a varying
number of eﬀective markers me.
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Figure 4.2: Dependence of  on me: Minimal eﬀect size required for the ROC to cross
through the points where sensitivity and speciﬁcity are equal to 0:9, 0:8 and 0:7
as a function of the number of eﬀective markers me.
4.6 Simulations results
We will now investigate the three diﬀerent selection procedures for constructing a linear score
discussed in Section 4.4 by simulation, assuming that two samples of patients responding to
a particular treatment and of patients not responding to the treatment are available. We ﬁx
the sample sizes as nr = nnr = n = 50, 100 and 500 per group and the candidate marker mea-
surements (m = 1000 and 6000) are assumed to follow independent normal distributions with
common known variance ﬀ2 = 1. For m0 markers the means are equal (the null hypothesis
is true) and for the remaining me = m(1 0) markers the same alternative r;i  nr;i = ,
i 2 E holds. Hence, the true mean diﬀerences between responders and non-responders are 
for the ke (ke  k) selected eﬀective markers. For the k0 = k ke selected ineﬀective markers
the mean diﬀerences are 0. Looking at the mean f and the variance ﬀ2f (see formula (4.2)) of
the prediction score (4.1) it is easy to see that the higher the proportion of ineﬀective markers
among the selected ones the smaller the mean distance between the two homoscedastic nor-
mal distributions of future responders and non responders, and hence the worse the prognosis.
We vary the number of eﬀective markers to be me = 10, 60 or 0. Diﬀerent FDR values
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for using the protected procedure and diﬀerent numbers k of "best" markers for using the
unprotected procedure are investigated. Also diﬀerent boundaries  when using the forward
logistic regression as selection method are investigated.
4.6.1 Variable selection using the protected approach
As discussed in Section 4.5, the eﬀect size  is triggered by forcing the optimal ROC-curve
through the benchmark point v = 1 w = 0:9, thus for me = 10,  = 0:81 and for me = 60,
 = 0:33.
me=10, m=1000
n=50
The sample size per group is ﬁrst ﬁxed to n = 50. Figures 4.3 show simulated ROC-
Curves (grey curves) for some FDR selection criteria assuming me = 10 eﬀective markers
(alternatives) among m = 1000 hypotheses. The "average" ROC is calculated from the
simulated samples, conditional that at least one marker has been identiﬁed by the selection
procedure (dashed curve). The quantity p^s is the proportion of samples among all simulation
steps where at least one marker has been identiﬁed for future prediction. The theoretically
achievable ROC-curve through the benchmark point (0:9; 0:9) is shown by the solid curve.
To compare the diﬀerent FDR selection criteria we calculated the area under the ROC-curve
(AUC) for an independent future patient (see formula (4.3)) for all simulated samples. Figure
4.4 (A) shows boxplots of the AUC-values of the simulated samples (10000 repetitions) for
diﬀerent FDR values chosen a priori for the selection of markers for future prediction, con-
ditional that at least one marker has been identiﬁed for future prediction. Note that in the
simulations for this scenario p^s = 1 if the FDR is larger than 0:01. When controlling a FDR of
0:00005, p^s = 0:67. The best performance, i.e. the largest average AUC among the grid of
investigated FDR values, further on denoted by AUCsim , occurs if selection is performed con-
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trolling a FDR of 0:15 and 0:20. For these two investigated values AUCsim = 0:941 which
is slightly smaller than the theoretically best achievable AUC of 0:965 of the ROC-curve
crossing through the benchmark point v = 1  w = (0:9; 0:9) (see the dotdashed horizontal
line in the Figures). If a larger FDR is chosen, more ineﬀective markers are tolerated in the
score but also more eﬀective marker are selected so that the score still performs well. Fixing
FDR= 0:15 in average 1:7 true null hypotheses and 8:6 alternatives (eﬀective markers) are
selected for future prediction. For FDR= 0:20 in average 2:4 true null hypotheses and 8:9 al-
ternatives are selected. This leads to a similar performance in terms of AUC values for future
prediction as for FDR= 0:15. However, if a too large FDR is chosen for selection, too many
ineﬀective markers are added so that the score gets worse, e.g. choosing the FDR= 0:95 the
average "future" AUC becomes much smaller (0:827) than AUC. Although in average all
10 alternatives are then selected, the prediction score additionally includes in average 374:8
true null hypotheses.
n=100
When increasing the sample size per group to n = 100 clearly the AUC values of the selected
scores also increase. Figure 4.4 (B) shows the situation assuming me = 10 eﬀective markers
among m = 1000 tested hypotheses for a sample size of n = 100 per group. The FDR
with the largest average AUC for future prediction among the investigated values (AUCsim )
is smaller than in the situation of n = 50 per group. Selection controlling a FDR of 0:01
and 0:05 leads to virtually the same performance with an AUCsim of 0:961 which is again
only slightly smaller than AUC = 0:965. In average 9:9 alternatives but only 0:6 true null
hypotheses are selected for a future prediction score when choosing FDR= 0:05. p^s = 1 for
all investigated FDR selection criteria ﬁxing the sample size to n = 100 per group. Figure 4.4
(B) shows that the resulting scores perform well for a wide range of FDR values. This may
be due to the better estimate of the true mean values (r;i and nr;i for i = 1; :::; m) and thus
to a better estimate of the weights of the selected markers in the score function when the
sample size increases. Therefore selection of one true null hypothesis (ineﬀective marker) has
a smaller impact on the overall performance than one selected alternative (eﬀective marker),
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since its weight in the score function is smaller, although its p-value is still signiﬁcant for
larger FDR values.
n=500
Figure 4.4 (C) shows the situation assuming a sample size of n = 500 per group. It seems
that for n = 500 it does not really mind which FDR is chosen as selection criteria, the re-
sulting score always performs good. Because of the large sample size, the p-values of the
alternatives are nearly 0 and thus mostly all alternatives are selected for future prediction.
As mentioned before, there is a better estimate of the mean values of the two groups and
thus, the weights of selected true null hypotheses are nearly null, although their p-values are
signiﬁcant for larger FDR values. This also interprets the average AUC of 0:945 for selection
using a FDR of 0:99. AUCsim = 0:965 occurs when choosing smaller selection criteria (up
to FDR= 0:01) and is equal to AUC. Always all 10 eﬀective markers but in average only up
to 0:1 ineﬀective markers (for FDR= 0:01) are selected for the prediction score.
me=60, m=1000
n=50
Let us now assume me = 60 alternatives among the m = 1000 tested hypotheses. The
sample size per group is again ﬁrst ﬁxed to n = 50. The eﬀect size  to achieve the theoret-
ical benchmark ROC-curve now is 0:33. Figures 4.5 again show simulated ROC-Curves (grey
curves) as well as the average curve (dashed line) and the theoretical benchmark ROC (solid
line) for some FDR selection criteria and Figure 4.6 (A) shows the boxplots of the AUC-values
of the simulated samples for the diﬀerent FDR selection criteria, conditional that at least
one marker was selected for future prediction. In this scenario p^s in the simulated samples
approaches 1 only if the FDR is larger than 0:60.
Again it is better to tolerate more ineﬀective markers and thus ﬁnd more eﬀective markers,
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however in this scenario it would be superior to chose a very large FDR as selection criterion.
Selection controlling a FDR of 0:8 and 0:85 leads to prediction scores with AUCsim = 0:813,
whereas selection controlling a FDR of e.g. 0:2 leads to scores with an average AUC of
only 0:691, which indicates a poor performance. Note also that for FDR= 0:2, p^s = 0:918,
that means that in 8:2% of the simulated samples no prediction score is selected from the
data. When controlling a FDR of 0:05 in only 58:2% of the simulated samples a prediction
score is selected from the data. Choosing FDR= 0:85 in average includes 51:6 alternatives
and 325:4 true null hypotheses in the score for future prediction. For FDR= 0:20 in av-
erage 2:0 true null hypotheses but only 6:7 out of the me = 60 alternatives are selected.
However, AUCsim = 0:813 is still much smaller than AUC = 0:965. It is interesting to see
that selection controlling a FDR of 0:95 results in a performance with an average AUC of
0:777 which is still good as compared to small FDR values. However, it remains the question
whether a score built with in average more than 800 markers is practical, although the future
performance is larger as compared to smaller FDR values.
n=100
Again increasing the sample size per group to n = 100 increases the AUC values of the
selected scores. Figure 4.6 (B) shows the situation assuming me = 60 eﬀective markers
among m = 1000 tested hypotheses ﬁxing the sample size to n = 100 per group. Again
the corresponding FDR where AUCsim occurs is smaller than in the situation of n = 50 per
group. AUCsim is 0:887 for selection controlling a FDR between 0:45 and 0:55. Choosing
FDR= 0:55 leads to a score including on average 47:0 eﬀective and 59:8 ineﬀective markers.
For a FDR above 0:10 the simulations show p^s = 1. Clearly with an increasing sample size
also p^s increases. Again this may be due to the better estimate of the true mean values r;i
and nr;i (i = 1; :::; m).
n=500
Figure 4.6 (C) shows the situation assuming a sample size of n = 500 per group. Again
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a good performance in terms of future AUC values can be seen over all investigated FDR
values. When selection is based on a FDR of 0:99, the average AUC is 0:925. The largest
average AUC for prediction of a future patient among the investigated FDR values (AUCsim )
of 0:961 occurs when choosing a FDR of 0:01 and 0:05. Fixing FDR= 0:05 in average 59:6
out of the 60 alternatives and 3:2 true null hypotheses are selected for future prediction.
Again, because of the large sample size, p^s is 1 for all investigated FDR values.
For more detailed information see Tables E.8 to E.13 in the appendix.
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Figure 4.3: Simulation results for the protected approach: simulated ROC-curves (1000 plot-
ted curves out of 10000 simulation steps) for a future patient for diﬀerent FDR-
values. 10 among 1000 hypotheses are assumed to be alternatives. The sample
size per group was set to n = 50. The average curve (dashed line) and the
theoretically best ROC-curve (solid line) is given.
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Figure 4.4: Boxplots of the area under the ROC-Curve for selection using the protected ap-
proach assuming me = 10 alternatives markers among m = 1000 tested markers
(10000 simulation steps). The sample size per group was set to n = 50 (Fig-
ure (A)), 100 (Figure (B)) and 500 (Figure (C)). AUC is given as dotdashed
horizontal line.  was set to 0:81.
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Figure 4.5: Simulation results for the protected approach: simulated ROC-curves (1000 plot-
ted curves out of 10000 simulation steps) for a future patient for diﬀerent FDR-
values. 60 among 1000 hypotheses are assumed to be alternatives. The sample
size per group was set to n = 50. The average curve (dashed line) and the
theoretically best ROC-curve (solid line) is given.
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Figure 4.6: Boxplots of the area under the ROC-Curve for selection using the protected ap-
proach assuming me = 60 alternatives markers among m = 1000 tested markers
(10000 simulation steps). The sample size per group was set to n = 50 (Fig-
ure (A)), 100 (Figure (B)) and 500 (Figure (C)). AUC is given as dotdashed
horizontal line.  was set to 0:33.
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me=10, m=6000
Let us furthermore have a look at the situation assuming me = 10 eﬀective markers (alter-
natives) among m = 6000 hypotheses. Because of the larger number of tested hypotheses
the problem to ﬁnd the alternatives becomes harder. The eﬀect size  remains the same,
thus  = 0:81 for me = 10 since it only depends on the number me of alternatives and not
on the number of tested hypotheses. Figure 4.7 (A) shows the situation ﬁxing the sample
size per group to n = 50. Clearly the average AUC values for the grid of investigated FDRs
are smaller as compared to the scenario with m only equal to 1000. Due to the large eﬀect
size assuming me = 10, selection controlling a FDR of 0:25 leads to good prediction scores
with an AUCsim of 0:918, although selecting out of 6000 hypotheses. Increasing the sample
size to n = 100 per group (Figure 4.7 (B)) AUCsim = 0:959 occurs for FDR= 0:05. The
results of a further increase of the sample size per group to n = 500 can be seen in Figure 4.7
(C). Again, as in the case of m = 1000, because of the good estimates of the group means
and the very small p-values of the alternatives, for a wide range of FDR values the future
performance remains good. Up to a FDR of 0:01, AUCsim for future prediction is almost
equal to the best theoretically achievable AUC. For larger FDR values the performance is
only slightly smaller. p^s = 1 in the simulations for all FDR selection criteria if n = 500 per
group.
me=60, m=6000
Assuming me = 60 among m = 6000 hypotheses,  = 0:33. Now the situation gets worse.
Because of the small eﬀect size and the larger number of hypotheses to test no good pre-
diction score can be selected if the sample size per group is small. Figure 4.8 (A) shows the
results of the simulations when ﬁxing the sample size per group to n = 50. When choosing
FDR= 0:9 as selection criterion on average only 28:7 out of the 60 alternatives and addi-
tionally a mean value of 350:5 true null hypotheses are selected which leads to prediction
scores achieving AUCsim = 0:669. Hence, AUC
sim
 is much smaller than AUC = 0:965.
This again describes exactly the problem of gene expression studies. If only a few eﬀective
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markers with a large eﬀect size exist it may be possible to ﬁnd good prediction scores if the
right selection criterium is used. In contrast, if there are many markers with low eﬀect sizes
working together, searching for prediction scores with rather small sample sizes becomes a
formidable problem. Note also that if selection is based on a FDR of 0:05 in only 26% of
the simulated samples a prediction score is selected from the data. Even if the FDR is 0:85
it happens that no prediction score is constructed from the data (p^s = 0:995).
Increasing the sample size to n = 100 per group (Figure 4.8 (B)) the situation improves
a little as compared to n = 50. However the best performance occurs for FDR= 0:6 with
AUCsim = 0:792. Then 26:7 out of the 60 alternatives and 43:1 true null hypotheses are
selected for future prediction. In the simulation studies p^ = 1 if the FDR is larger than 0:40.
A further increase of the sample size per group to n = 500 changes the situation completely
(see Figures 4.8 (C)). Again, for a wide range of FDR values the future performance remains
good. The largest average AUC among the investigated FDR values (AUCsim ) occurs for
FDR= 0:05. In average 58:5 eﬀective and 3:1 ineﬀective markers are selected which lead
to prognostic scores with AUCsim = 0:959. p^s = 1 in the simulations for all FDR selection
criteria if n = 500 per group.
For more detailed information see Tables E.8 to E.13 in the appendix.
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Figure 4.7: Boxplots of the area under the ROC-Curve for selection using the protected ap-
proach assuming me = 10 alternatives markers among m = 6000 tested markers
(10000 simulation steps). The sample size per group was set to n = 50 (Fig-
ure (A)), 100 (Figure (B)) and 500 (Figure (C)). AUC is given as dotdashed
horizontal line.  was set to 0:81.
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Figure 4.8: Boxplots of the area under the ROC-Curve for selection using the protected ap-
proach assuming me = 60 alternatives markers among m = 6000 tested markers
(10000 simulation steps). The sample size per group was set to n = 50 (Fig-
ure (A)), 100 (Figure (B)) and 500 (Figure (C)). AUC is given as dotdashed
horizontal line.  was set to 0:33.
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4.6.2 Variable selection using forward logistic regression
For selection using the forward logistic regression, again  was set to 0:81 in the case of
me = 10 and to 0:33 for me = 60. Because of run-time problems, simulations (1000 simu-
lation steps) were only performed for m = 1000. Diﬀerent thresholds were applied for the
individual p-values in the stepwise selection based on the multiple logistic regression. Those
thresholds  where determined corresponding to the rejection boundary when controlling the
FDR of 0:02, 0:05, 0:2 and 0:3 in a conventional single-stage design. Thus for me = 10
we used  = 0:0002, 0:0005, 0:0025 and 0:0043 and for me = 60,  = 0:0001, 0:0006,
0:0073 and 0:0015. We additionally performed simulations using the Bonferroni correction to
calculate the threshold ( = 0:00005) as well as the situation were no correction ( = 0:05)
is performed.
Figures 4.9 and 4.10 show the ROC-curves (grey curves), the average ROC (dashed line) and
the theoretically best ROC (solid line) for the diﬀerent  values for the situation of me = 10
and 60 respectively. The simulation results of the forward logistic regression show that this
selection method for the investigated scenarios performs poor in terms of AUC values for
prediction of the outcome of future patients as compared to the selection procedure using
the FDR approach. Figure 4.11 shows boxplots of the AUC values for future prediction us-
ing the forward logistic regression for the diﬀerent  values for me = 10 (ﬁrst column) and
me = 60 (second column) among m = 1000 hypotheses considering a sample size of n = 50
(ﬁrst row) and n = 100 per group (second row). The poor result may be due to the fol-
lowing reason: in a small training sample the forward logistic regression leads to a complete
separation of data points, i.e. responders and non-responders of the validation data set can
be fully separated with the found regression model. Only a few eﬀective markers are selected
for future prediction using the forward logistic regression.
The best performance for the situation of me = 10 occurs for  = 0:0005 with AUCsim =
0:812 for n = 50 and again at  = 0:0005 with AUCsim = 0:900 for n = 100. The forward
logistic regression applying a larger sample size clearly performs better. However, AUCsim for
86
4.6 Simulations results
the selection procedure using the FDR was 0:941 for n = 50 and 0:961 for n = 100. Note
that for n = 50 in average only 2:881 and for n = 100 only 5:644 out of the 10 alternatives
are selected using the logistic regression.
In the case of me = 60 for  = 0:0073 up to 0:05 the mean AUC on average is 0:613
for n = 50. Because of complete separation of data points for larger  values, the same
performance is achieved for   0:0073. Setting n = 100 per group a similar result can be
seen. Again choosing   0:0073 leads to the same performance achieving AUCsim = 0:696.
Note that AUCsim for selection using the FDR was 0:813 for n = 50 and 0:887 for n = 100
per group. However, the theoretically achievable AUC is 0:965, which is not achieved with
both selection methods. Note also that if  was chosen to be 0:00005, only in 26% of the
simulated samples a prediction score is selected from the data if n = 50 and in 86:3% if
n = 100 per group.
For more detailed information see Table E.7 to in the appendix.
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Figure 4.9: Simulation results using forward logistic regression (1000 steps): simulated ROC-
curves for a future patient for diﬀerent values of . 10 among 1000 hypotheses
are assumed to be alternatives. The sample size per group was set to n = 50.
The average curve (dashed line) and the theoretically best ROC-curve (solid line)
is given.
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Figure 4.10: Simulation results using forward logistic regression (1000 steps): simulated
ROC-curves for a future patient for diﬀerent values of . 60 among 1000 hy-
potheses are assumed to be alternatives. The sample size per group was set to
n = 50. The average curve (dashed line) and the theoretically best ROC-curve
(solid line) is given.
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Figure 4.11: Boxplots of the area under the ROC-Curve for 1000 simulated samples for se-
lection using forward logistic regression assuming me = 10 (ﬁrst column) and
me = 60 (second column) eﬀective markers among m = 1000 tested markers
and assuming a sample size of n = 50 (ﬁrst row) and n = 100 (second row).
AUC is shown as dotdashed horizontal line. Results for diﬀerent  values are
given.
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4.6.3 Variable selection using the optimistic approach
The eﬀect size is again set to  = 0:81 if me = 10 and  = 0:33 if me = 60, thus forcing
the optimal ROC-curve through the point where sensitivity and speciﬁcity are equal to 0:9.
Note that for the optimistic approach selecting the best k markers, ps  1, thus always a
prediction score is selected from the data.
m=1000
Figures 4.12 show simulated ROC-curves (grey curves) for some k assuming me = 10 among
m = 1000 hypotheses. Again the average ROC calculated from the samples (dashed curve)
and the theoretically best curve (solid curve) are given. Figure 4.13 (A) shows boxplots of
the future AUC values for diﬀerent values of k ﬁxing the sample size per group n = 50.
AUCsim = 0:942 occurs when selecting the best 10 hypotheses. In average 8:6 eﬀective and
thus 1:4 ineﬀective markers are included in the prediction score. When increasing the sample
size per group to n = 100 (Figure 4.13 (B)) again the best performance among the scenarios
considered in the simulations is achieved for k = 10 with an AUCsim of 0:962. As for the
FDR-selection criterion for larger sample sizes the mean values for the group of responders
and non-responders can be better estimated and thus also for larger values of k the perfor-
mance still remains good. This can be also seen in the case of n = 500 (see Figure 4.13 (C)).
Figures 4.14 show simulated ROC-curves (grey curves) as well as the average curve (dashed
line) and the theoretically best ROC-curve (solid line) for some k assuming me = 60 among
m = 1000 hypotheses. Figure 4.15 (A) shows boxplots of the future AUC values for diﬀerent
values of k for this scenarios for a sample size per group of n = 50. Now the optimum is
very ﬂat. A similar performance with an AUCsim between 0:813 and 0:814 can be achieved
varying k from 150 to 600. If k is set to 600, in average 541:9 true null hypotheses and 58
alternatives are selected. However, the large number of markers may result in a unfeasible
score. If selecting the best 150 hypotheses, in average 40:6 alternatives and 109:4 true null
hypotheses are selected which lead to a similar average future AUC. Choosing k = me = 60
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on average 33:5 true null hypotheses but only 26:5 out of the 60 alternatives are selected for
a future prediction which results in an average AUC of only 0:80. Fixing the sample size to
n = 100 (Figure 4.15 (B)), among the considered scenarios, AUCsim = 0:888 is achieved for
k = 100. Again only a slight decrease of the mean AUC can be seen when using a larger k
(see also Figure 4.15 (C) for a sample size of n = 500). Note that a large decrease of the
mean AUC occurs if k is smaller than me, as in the case of k = 5 where the mean future
AUC is only 0:695 assuming a sample size of n = 100 per group.
m=6000
Figures 4.16 (A) and 4.17 (A) show the situation when increasing the number of tested
hypotheses to 6000. The result is similar as for selection using the FDR approach. If the
number of alternatives is small, but their eﬀect size is large one may get a good prediction
score even if the sample size is small. For larger sample sizes, the estimates of the group
means and thus of the weights in the score get more precisely. For a larger range of k the
performance remains good. If a larger number of alternatives is expected with a rather small
eﬀect size one may not get a good prediction score applying a small sample size. Assuming
me = 60 and applying a samples size of n = 50 per group, the average AUC values over
all investigated k are not exceeding 0:7. For a larger sample size per group the situation
clearly gets better, for a sample size of n = 500 per group, the best performance occurs if
k = 60(= me) achieving an AUCsim of 0:959.
For more detailed information see also Tables E.1 to E.6 in the appendix.
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Figure 4.12: Simulation Results for the protected approach: simulated ROC-curves (1000
plotted curves out of 10000 simulation steps) for a future patient for diﬀerent
values of k . 10 among 1000 hypotheses are assumed to be alternatives. The
average curve (dashed line) and the theoretically best ROC-curve (solid line) is
given.
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Figure 4.13: Boxplots of the area under the ROC-Curve for selection using optimistic ap-
proach assuming me = 10 alternatives markers among m = 1000 tested markers
(10000 simulated samples). The sample size per group was set to n = 50 (Fig-
ure (A)), 100 (Figure (B)) and 500 (Figure (C)). AUC is given as dotdashed
horizontal line.  was set to 0:81.
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Figure 4.14: Simulation Results for the protected approach: simulated ROC-curves (1000
plotted curves out of 10000 simulation steps) for a future patient for diﬀerent
values of k . 60 among 1000 hypotheses are assumed to be alternatives. The
average curve (dashed line) and the The theoretically best ROC-curve (solid
line) is given.
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Figure 4.15: Boxplots of the area under the ROC-Curve for selection using optimistic ap-
proach assuming me = 60 alternatives markers among m = 1000 tested markers
(10000 simulated samples). The sample size per group was set to n = 50 (Fig-
ure (A)), 100 (Figure (B)) and 500 (Figure (C)). AUC is given as dotdashed
horizontal line.  was set to 0:33.
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Figure 4.16: Boxplots of the area under the ROC-Curve for selection using optimistic ap-
proach assuming me = 10 alternatives markers among m = 6000 tested markers
(10000 simulated samples). The sample size per group was set to n = 50 (Fig-
ure (A)), 100 (Figure (B)) and 500 (Figure (C)). AUC is given as dotdashed
horizontal line.  was set to 0:81.
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Figure 4.17: Boxplots of the area under the ROC-Curve for selection using optimistic ap-
proach assuming me = 60 alternatives markers among m = 6000 tested markers
(10000 simulated samples). The sample size per group was set to n = 50 (Fig-
ure (A)), 100 (Figure (B)) and 500 (Figure (C)). AUC is given as dotdashed
horizontal line.  was set to 0:33.
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Figure 4.18: ROC-Curves: Situation under global null hypothesis
4.6.4 Situation under the global null hypothesis
Figure 4.18 shows the situation under the global null hypothesis of no existing eﬀective mark-
ers at all (me = 0). The ROC curve is always the diagonal (AUC= 0:5). Whatever selection
procedure is used, if markers are selected, they are always true null hypotheses and thus the
prediction score is useless. For the protected procedure, i.e. selection using the FDR ap-
proach, by deﬁnition the probability to end with a selection of markers and building a score is
targeted at the pre-chosen FDR. Hence in the case of the global null hypotheses it would have
been better to chose a small FDR. However, if a large number of alternatives are expected
with rather small eﬀect sizes a very large FDR should be chosen as selection criterion. The
unprotected procedure, selecting the k best markers for prediction, leads to a completely
non-informative score in all cases (per deﬁnition, ps  1).
If we select markers using the forward logistic regression, as for the FDR selection method,
the results depend on the boundary  chosen a priori. E.g. if we decided for Bonferroni cor-
rected boundaries in only 2:9% of the 1000 simulated cases at least one marker was identiﬁed
for future prediction but when increasing  to 0:0025 in 98:3% useless prediction scores are
produced. Without correction ( = 0:05) p^s = 1.
This again demonstrates the dilemma of the task we are faced with. It may be possible
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to improve the selection and estimation procedures but a contradiction will remain: being
cautious may help not to produce too many nuisance results if the postulated relationships do
not exist. Being more optimistic and liberal may improve the results, particularly if the true
state of a nature is close to what the selection procedure is targeted at, e.g., if in our case
k is close to the actual number of eﬀective markers. However the unprotected procedure
is vulnerable for the situations of no existing eﬀects. Here it will always produce nuisance
results and due to a large number of tests the magnitude of the observed best eﬀects may
mislead the experimenter.
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4.7 Estimating the selection criterion using jackknife
4.7.1 Jackknife for the protected approach
We have seen from the previous sections that the forward logistic regression may not be a
good selection procedure if small sample sizes are given. There are simple methods, like using
the FDR approach and just building a weighted sum of the selected hypotheses, which, if
the right selection boundary is chosen, lead to a better performance in terms of AUC values
for prediction of the outcome of a future patient. However, it remains the question, how to
choose the selection boundary, because depending on the parameter constellation (varying
number of tested hypotheses, varying proportion of eﬀective markers and varying sample
size), diﬀerent boundaries are required in order to achieve a large AUC for future independent
patients.
The procedure
To estimate an appropriate selection boundary  for the protected method we will now in-
vestigate a modiﬁed Jackknife procedure. The marker levels are again assumed to follow
independent normal distributions with known variance ﬀ2 = 1.
From a given data set with n responders and n non-responders, a pair of a single responder
and a single non-responder respectively is left out. Note that there are j = 1; :::; n2 possibili-
ties for leaving out a pair of one responder and one non-responder. The 2(n  1) patients in
each of the n2 "training" samples respectively are used to estimate prediction scores applying
a grid of values i , i = 1; :::s, for the selection boundary. As discussed in Section 4.3.1, the
markers, whose one sided p-values lie below the selection boundary i are selected for future
prediction. For the left out responder and non-responder respectively we now calculate for
each i , i = 1; :::s, the value of the corresponding prediction score:
f^j(xr;j ; i) = (^r;(j)(i)  ^nr;(j)(i))Txr;j
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and
f^j(xnr;j ; i) = (^r;(j)(i)  ^nr;(j)(i))Txnr;j
where ^r;(j)(i) and ^nr;(j)(i) are the mean values of the group of responders and non-
responders respectively of the markers selected for prediction, calculated from the jth training
sample, using i as selection boundary. The notation ^a;(j)(i), a = r; nr , indicates that the
length of the vector is nondecreasing in i ; xr;j and xnr;j denote the corresponding values of
the selected markers of the single responder and non-responder respectively left out in the
construction of the score. Now for each investigated i the following function is calculated:
dj(xr;j ; xnr;j ; i) =

0 if f^j(xr;j ; i) < f^j(xnr;j ; i)
1 if f^j(xr;j ; i) > f^j(xnr;j ; i)
0:5 if f^j(xr;j ; i) = f^j(xnr;j ; i)
: (4.5)
If no prediction score is selected from the data, dj(xr;j ; xnr;j ; i) = 0:5. The values of
dj(xr;j ; xnr;j ; i) for each i , i = 1; :::; s, are now calculated for all j = 1; :::; n2 training
samples. Note that in our balanced scenario overall we use n2 pairs of a single responder and
non-responder as validation sample. For each i we can calculate a "jackknife based" AUCi :
AUCi =
1
n2
n2∑
j=1
dj(xr;j ; xnr;j ; i): (4.6)
This is the way the AUC would be calculated in the independent sample case (see e.g. Acion
et al. (2006)). Finally we choose the selection boundary ^ such that it maximizes AUCi :
^ = arg max
i ;i=1;:::;s
n2∑
j=1
dj(xr;j ; xnr;j ; i) (4.7)
If more than one i fulﬁlls this jackknife criterion (4.7), the minimum of these i values is
chosen as ﬁnal selection boundary.
We decided to search for the optimal i instead of the optimal FDR because of the ex-
tremely longer runtime needed to search for the corresponding i values in each training set.
For the ﬁnal selection boundary ^ the FDR can be estimated with Storey's estimator (see
formula (2.6)) in the total sample. However, this estimator may be biased.
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Additionally the probability that at least one true null hypotheses is selected for future pre-
diction
FWER^ = (1  (1  ^)m0) (4.8)
can be calculated. Despite the long runtime, for some scenarios we performed simulations of
the procedure searching for the optimal FDR. The results are very similar.
Simulation results
To investigate the jackknife procedure we performed simulations for the scenarios assuming
me = 10 and 60 among m = 1000 and 6000 hypotheses for n = 50 per group. For the
scenarios with m = 1000 tested hypotheses we also investigated the procedure for n = 100.
me = 10, m = 1000
Figures 4.19 show the results of the jackknife procedure assuming 10 alternatives among
1000 hypotheses and ﬁxing the sample size to n = 50 per group. Figure 4.19 (A) shows the
"jackknife based" AUCi (see formula 4.6) as a function of i (i = 1; ::; s). The grey curves
show AUCi of the 500 simulated samples and the black solid curve shows the mean value
over the samples. For smaller values of i on average larger jackknife based AUC values are
achieved. Figure 4.19 (B) shows a boxplot of the ﬁnal selection boundaries ^ determined
from (4.7). The jackknife procedure results in a median ^ of 0:0021 (mean: 0:0052).
Figure 4.19 (C) shows boxplots of the estimated ̂FDR using Storey's estimator (see Formula
(2.6)) for the diﬀerent samples and the actual (true) FDR calculated from the samples. A
boxplot of the asymptotic FDR^;1 calculated from the ﬁnal selection boundaries ^, assuming
that 0 and  are known can also be seen in Figure 4.19 (C). FDR^;1 is calculated as in
formula (3.3) using
1  (^) = 1 p n
2
;1
(c1 ^)
for the power. The jackknife procedure results in a mean ̂FDR of 0:243 (median: 0:19)
which is only slightly smaller than the mean actual FDR of 0:254 (median: 0:2). Note that
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the average asymptotic FDR^;1 is 0:256 (median: 0:19). Note also that if in the calculation
of ̂FDR the estimated ^0 is larger than 1, we set it to 1 (see Section 2.3.2). If no such
correction of ^0 is applied, the average ̂FDR is slightly larger that the actual FDR (mean:
0:265).
It remains the question how well the FDR is estimated when the threshold for the FDR
is estimated itself from the re-sampling procedure and hence is a random variable. E.g. Gen-
ovese and Wasserman (2004) have given conditions for which asymptotically for large m (and
large sample sizes) Storey's estimate for (random) thresholds is exceeding the true FDR with
a given probability. To investigate the bias of the estimated FDR we calculated the diﬀerence
between the estimated and the actual FDR (further on denoted by "bias"). Figure 4.19 (D)
shows the boxplot of the diﬀerences which vary around 0.
A boxplot of the maxima of the jackknife based AUCi values, AUC^ = max
i
AUCi , over
the simulated samples can be seen in Figure 4.19 (E). The average AUC^ is 0:956. Figure
(E) also shows a boxplot of the AUC^(x) values for the prediction of the outcome of a future
patient (with marker values x) calculated with formula (4.3) using the mean value f and the
variance ﬀ2f (see formula (4.2)) of each simulated sample. The average "future" AUC^(x)
is 0:934. The theoretically best achievable AUC = 0:965 is shown as dotdashed horizontal
line. Note that AUC^ calculated from the data may be larger than AUC^(x) for prediction
of a future patient and thus also larger than AUC.
Remember that the previous simulations in Section 4.6.1 (see Figure 4.4 (A)) showed that
the largest average future AUC over the investigated FDR values (AUCsim ) occurs for a FDR
of 0:15 and 0:2. Thus for this scenario, the selection boundaries ^ found with the jackknife
procedure lead to a median ̂FDR value which lies within the area where AUCsim was found.
Figure 4.19 (F) shows a boxplot of the FWER^ values (see formula (4.8)) assuming that 0
is known. The mean value is 0:756 (median: 0:875). The actual FWER calculated from the
500 samples is 0:76.
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Note that if more than one i fulﬁlls the jackknife criterion (4.7), we choose the small-
est i as selection boundary for future prediction. Since the i values which achieve the same
value lie within a small range, the results of the jackknife procedure when using the largest
i instead of the smallest are similar.
Increasing the sample size to n = 100 per group the jackknife procedure again performs
good when assuming me = 10. Note that for n = 100 there are n2 = 10000 possibilities
of leaving out a pair of one responder and one non-responder respectively. A median ^ of
0:0008 (mean: 0:0026) was found from the jackknife procedure which corresponds to a
median actual FDR of 0:091 (mean: 0:1637) leading to a mean future AUC^(x) of 0:958,
which is again only slightly smaller than AUCsim of 0:961 found from the previous simulations
(compare Figure 4.4 (B)). The average jackknife based AUC^ is 0:965.
me = 60, m = 1000
Figures 4.20 show the results of the jackknife procedure assuming me = 60 alternatives
among m = 1000 hypotheses and again applying a sample size of n = 50 per group. Figure
4.20 (A) shows that the jackknife based AUCi increases for increasing values of i , however,
the mean curve (black line) is ﬂat for larger i . A boxplot of the ﬁnally chosen ^ values for
the simulated samples is shown in Figure 4.20 (B). The median ^ found from the jackknife
procedure is 0:06 (mean: 0:097) which corresponds to a median estimated ̂FDR of 0:643
(mean: 0:615, Figure 4.20 (C)). The median actual FDR is 0:645 (mean: 0:604, Figure
4.20 (C)). Note that in this scenario the mean estimated ̂FDR is only slightly larger than
the mean actual FDR, hence, the diﬀerence between both FDR values again varies around
0 (Figure 4.20 (D)), however, varying more than in the situation of me = 10. The median
asymptotic FDR^;1 is 0:636 (mean: 0:613). Figure 4.20 (E) again shows boxplots of AUC^
achieved for the ﬁnal selection boundaries ^ and the resulting future AUC^(x) for the pre-
diction of the outcome of a future patient. The average AUC^ is 0:868 as compared to a
mean future AUC^(x) of 0:796, which is smaller than AUCsim = 0:813 observed from the
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previous simulations (compare Figure 4.6 (A)) and was achieved when controlling a FDR of
0:8 and 0:85. As expected in the situation of many eﬀective marker with a rather small eﬀect
size the jackknife procedure works not as good as in the situation of a few alternatives with
large eﬀects. A smaller FDR is obtained from the jackknife procedure, however, because of
the ﬂat optimum with similar results over a wide range of FDR values, the performance in
terms of the future AUC^(x) is still good. The median FWER^ in this scenario is 1 (mean:
0:988, Figure 4.20 (F)). The actual FWER calculated from the 500 simulation steps is 0:984.
Increasing the sample size to n = 100, the jackknife procedure results in a median ^ of 0:032
(mean: 0:044), which corresponds to a median actual FDR of 0:432 (mean: 0:405) leading
to a mean AUC^(x) of 0:882. The mean AUC^(x) is only slightly smaller than AUCsim of
0:887 which in the previous simulations occurred for a FDR between 0:45 and 0:55 (compare
Figure 4.6 (B)). On average an AUC^ of 0:957 is achieved. As expected, with an increased
sample size of n = 100 per group the jackknife procedure performs better. The ^ and FDR
values found from the jackknife procedure lead to only slightly smaller performances in terms
of future AUC^(x) values than found from our previous simulations.
me = 10, m = 6000
From the simulations in the previous sections it can be seen that when increasing the number
of tested hypotheses to m = 6000 it is more diﬃcult to ﬁnd the eﬀective markers. How-
ever, for me = 10 we may get a good performance of AUCsim = 0:918 if the FDR is set
to 0:25 (see Figure 4.7 (A)). Note that in order to get an overview of the scenario and
to save runtime we only performed 100 simulation steps for the jackknife procedure. The
jackknife procedure results in a median ^ of 0:0005 (mean: 0:0011, see Figure 4.21 (B))
corresponding to a median estimated ̂FDR of 0:250 (mean: 0:286, Figure 4.21 (C)) leading
to a mean future AUC^(x) of 0:910 (Figure 4.21 (E)) which is again only slightly smaller
than AUCsim . The average estimated
̂FDR is slightly smaller than the mean actual FDR
of 0:298 (median: 0:226), the diﬀerence again varying around 0 (Figure 4.21 (D)). The
mean asymptotic FDR^;1 is 0:314 (median: 0:260). The jackknife procedure again found
106
4.7 Estimating the selection criterion using jackknife
estimated ̂FDR values that lead to a good performance in terms of future AUC^(x) values.
The mean jackknife based AUC^ is 0:945 (Figure 4.21 (E)). Again the probability of at least
one false positive is very large. The average FWER^ is 0:787 (median: 0:933). The actual
FWER calculated from the 100 simulation steps performed for m = 6000 is 0:75.
me = 60, m = 6000
Assuming me = 60 alternatives among the 6000 hypotheses resulted in a very poor per-
formance of the selected prediction scores (see Figure 4.8 (A)). An AUCsim of 0:669 was
achieved for FDR= 0:9. The jackknife procedure results in a median selection boundary ^
of 0:013 (mean: 0:034, see Figure 4.22 (B)) corresponding to a median estimated ̂FDR of
0:835 (mean: 0:812, see Figure 4.22 (C)). The median actual FDR is 0:817 (mean: 0:783).
The mean estimated ̂FDR is again slightly larger than the mean actual FDR, however again
the diﬀerence is varying around 0 (see Figure 4.22 (D)). Note that the median asymptotic
FDR^;1 calculated from the ^ values assuming that 0 and  are known is 0:820 (mean:
0:801). The selection boundaries calculated with the jackknife procedure lead to a mean
future AUC^(x) of 0:667 (see Figure 4.22 (E)). The mean jackknife based AUC^ is 0:802.
Only a very small AUCsim in this scenario was obtained from the simulations, however the
jackknife procedure leads to a mean AUC^(x) which is only slightly smaller than AUCsim .
Note that the average FWER^ is 0:998 (median: 1) and the actual FWER calculated from
the simulated samples is 0:98
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Figure 4.19: Simulation results (500 repetitions) of the Jackknife procedure applying the
protected approach: AUCi as a function of i (Figure (A)) as well as boxplots
of the ﬁnal selection boundary ^ (B), the resulting estimated ̂FDR, actual
FDR and asymptotic FDR^;1 (C), the bias of the estimated FDR (D), the
jackknife AUC^ and the future AUC^(x) (E) and FWER^ (F) for the situation
of me = 10, m = 1000, n = 50.
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Figure 4.20: Simulation results (500 repetitions) of the Jackknife procedure applying the
protected approach: AUCi as a function of i (Figure (A)) as well as boxplots
of the ﬁnal selection boundary ^ (B), the resulting estimated ̂FDR, actual
FDR and asymptotic FDR^;1 (C), the bias of the estimated FDR (D), the
jackknife AUC^ and the future AUC^(x) (E) and FWER^ (F) for the situation
of me = 60, m = 1000, n = 50.
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Figure 4.21: Simulation results (100 repetitions) of the Jackknife procedure applying the
protected approach: AUCi as a function of i (Figure (A)) as well as boxplots
of the ﬁnal selection boundary ^ (B), the resulting estimated ̂FDR, actual
FDR and asymptotic FDR^;1 (C), the bias of the estimated FDR (D), the
jackknife AUC^ and the future AUC^(x) (E) and FWER^ (F) for the situation
of me = 10, m = 6000, n = 50.
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Figure 4.22: Simulation results (100 repetitions) of the Jackknife procedure applying the
protected approach: AUCi as a function of i (Figure (A)) as well as boxplots
of the ﬁnal selection boundary ^ (B), the resulting estimated ̂FDR, actual
FDR and asymptotic FDR^;1 (C), the bias of the estimated FDR (D), the
jackknife AUC^ and the future AUC^(x) (E) and FWER^ (F) for the situation
of me = 60, m = 6000, n = 50.
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4.7.2 Jackknife for the optimistic approach
The jackknife procedure described for the protected method can be easily applied to the
unprotected method selecting the best k markers for future prediction by searching within a
grid of values of ki instead of the i values. The jackknife criterion is given by replacing i
by ki in formulas (4.7) and (4.5). The procedure itself remains the same.
m=1000
Figures 4.23 and 4.24 shows the results of the jackknife procedure for selection of best k if
me = 10 and me = 60 alternatives (eﬀective markers) are assumed among 1000 hypothe-
ses. The sample size per group is ﬁxed to n = 50 per group. For me = 10 the jackknife
procedure results in a median k^ of 11 (mean: 14:58, Figure 4.23 (A)), which achieves the
largest jackknife based AUCk^ and leads to a mean AUCk^(x) for future prediction of 0:939
(Figure 4.23 (B)). The average AUCk^ is 0:959 (Figure 4.23 (B)). A median number of 9
(mean: 8:8) out of the 10 alternatives are selected for future prediction. Remembering the
simulations in Section 4.6.3 (see Figure 4.13 (A)), AUCsim = 0:942 was found for k = 10.
The jackknife procedure results in k^ values which in average lead to only a slightly smaller
future performance.
For the situation of me = 60 alternatives among 1000 hypotheses a median k^ of 125 (mean:
212:99) was determined from the jackknife procedure (see Figures 4.24), which leads to a
mean AUCk^(x) of 0:809 which is slightly smaller than AUC
sim
 found in the simulations. Note
that the optimum of the average AUC depending on k was very ﬂat. Virtually the same
performance of in average 0:814 was achieved for k = 150 to 600 (see Figure 4.15 (A)).
Note that the average AUCk^ is 0:866 which is again larger than the average AUCk^(x) for pre-
diction of a future patient. A median number of 38 (mean: 39:8) out of the 60 alternatives
are selected for future prediction.
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m=6000
Increasing the number of tested markers to 6000 the jackknife procedure for me = 10 again
performs well (see Figures 4.25). The jackknife procedure found a median k^ of 9 (mean:
13:04) which results in an average AUCk^(x) of 0:915 which is again only slightly smaller than
AUCsim of 0:919 found in our simulations (compare Figure 4.16 (A)). A median number of
8 (mean: 7:7) out of the 10 alternatives are selected for future prediction. The mean AUCk^
is 0:946. Although the overall results in terms of future AUC values assuming me = 60
alternatives among 6000 hypotheses are poor over the investigated values of k (compare
Figures 4.17) and the optimum is very ﬂat, the jackknife procedure resulted in a median
k^ = 148 (mean: 242:05, see Figures 4.26) leading to prediction scores with an average
AUCk^(x) of 0:671 which is again only slightly smaller than AUC
sim
 of 0:673 achieved for
k between 200 and 300. The average jackknife AUCk^ is 0:769. A median number of 21:5
(mean: 23:4) out of the 60 alternatives is selected for future prediction.
Figure 4.23: Simulation results (500 repetitions) for the Jackknife procedure applying the op-
timistic approach by selection of the best k markers: Boxplots of the k^ resulting
from the jackknife procedure (Figure (A)) as well as AUCk^ and AUCk^(x) (Figure
(B)) for the situation of me = 10, m = 1000, n = 50.
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Figure 4.24: Simulation results (500 repetitions) for the Jackknife procedure applying the op-
timistic approach by selection of the best k markers: Boxplots of the k^ resulting
from the jackknife procedure (Figure (A)) as well as AUCk^ and AUCk^(x) (Figure
(B)) for the situation of me = 60, m = 1000, n = 50.
Figure 4.25: Simulation results (100 repetitions) for the Jackknife procedure applying the op-
timistic approach by selection of the best k markers: Boxplots of the k^ resulting
from the jackknife procedure (Figure (A)) as well as AUCk^ and AUCk^(x) (Figure
(B)) for the situation of me = 10, m = 6000, n = 50.
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Figure 4.26: Simulation results (100 repetitions) for the Jackknife procedure applying the op-
timistic approach by selection of the best k markers: Boxplots of the k^ resulting
from the jackknife procedure (Figure (A)) as well as AUCk^ and AUCk^(x) (Figure
(B)) for the situation of me = 60, m = 6000, n = 50.
4.7.3 Jackknife under the global null hypothesis
When using the protected procedure based on a multiple test controlling the FDR, the prob-
ability to end with useless prediction scores is targeted at the pre-chosen FDR. However,
if we expect a large number of eﬀective markers with rather small eﬀects choosing a large
FDR would be superior. Under the global null hypothesis the modiﬁed jackknife procedure
to select decision boundaries which produce "best" cross validated ROC-curve will lead to
select scores, however, they are useless for future patients.
Figures 4.27 and 4.28 show the results for the jackknife procedures under the global null
hypothesis of no eﬀective marker at all for selection using the protected approach assuming
a sample size of n = 50 and n = 100 per group respectively if a overall number of 1000
hypotheses are tested. The average curve of the jackknife based AUCi over the simulated
samples as a function of i is nearly a horizontal line at AUCi = 0:5, indicating that no pre-
diction score can be selected (Figures (A)). However, the jackknife procedure is searching for
the selection boundary which maximizes this jackknife based AUCi so that in most cases the
jackknife procedure will choose a prediction score in case of the global null (see the boxplots
115
4 Prognostic scores based on gene expression or proteomic data
for the jackknife based ^: Figures 4.27 and 4.28 (B)). Only in a few simulation steps no
prediction score is calculated (3:2% of the 500 steps if n = 50 and 2:2% if n = 100) under
the global null. Note that in the scenarios simulated if the alternative holds (as considered
in the previous sections), in all simulated samples a prediction score was selected from the
data. A median ^ of 0:0115 (mean: 0:0336) is found as ﬁnal selection boundary if n = 50
and of 0:008 (mean: 0:0234) if n was set to 100 per group.
Figure 4.29 shows the results of the jackknife procedure testing 6000 hypotheses ﬁxing
n = 50 per group. A median ^ of 0:0016 (mean: 0:0029, see Figure 4.29 (B)) is found
as ﬁnal selection boundary. Again the average AUCi -curve is nearly horizontal at 0:5 (Figure
4.29 (A)). No prediction score was calculated in 6% of the 100 simulation steps.
The results when applying the optimistic approach are similar. Again the mean curve of
the jackknife based AUCki over the simulated samples for the investigated ki is nearly a hor-
izontal line at AUC= 0:5 (see Figure 4.30 (A) if m = 1000 and 4.31 (A) if m = 6000).
However, the median jackknife based k^ chosen when the global null hypotheses is true is
7 (mean: 18:67, Figure 4.30 (B)) if m = 1000 and 5:5 (mean: 21:1, Figure 4.31 (B)) if
m = 6000. In both scenarios n is set to 50.
To get a hint that the global null hypotheses is true it would be useful to look at the quality
obtained by cross validated ROC-curves itself, e.g., in terms of the jackknife based AUC^
achieved with the ﬁnal selection boundaries ^. Figure 4.32 shows the distribution of the
jackknife based AUC^ of the simulated samples for selection applying the protected approach
for the situations of me = 10 (ﬁrst row) and 60 (second row) among 1000 tested hypotheses
as well as under the global null hypotheses (third row) ﬁxing the sample size to n = 50
(ﬁst column) and n = 100 (second column). The histograms show that in case of me > 0
AUC^ is generally larger than 0:8 whereas in case of the global null AUC^ is generally be-
low 0:8. Thus, in this situation one criterion could be the following: if the AUC^ resulting
from the jackknife procedure is smaller than, e.g. 0:8 then it seems to be preferable not to
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construct any score at all. Applying a sample size of n = 100 per group there is no overlap
between the distributions under the alternative and under the global null hypothesis in the
simulated samples. Expecting me = 60 and ﬁxing n = 50 per group in 90:8% of the simulated
samples AUC^ is larger than 0:8, under the global null, in only 2:6% of the simulated samples.
Increasing the number of tested hypotheses to 6000 in the situation of me = 10 again
AUC^ is always larger than 0:8. However, when expecting a larger number of alternatives
with rather small eﬀect sizes the distribution of AUC^ overlaps the distribution under the
global null on a larger area. Deciding to construct a score if the AUC^ is larger than 0:8
would lead to a false negative decision in 55% of the simulated samples. Decreasing the
boundary to 0:7 in only 8% no prediction score would be constructed. However, under the
global null hypotheses in 29% of the simulated samples AUC^ is above 0:7. Note that the
sample size in these scenarios is set to n = 50 per group.
Figure 4.27: Simulation results (500 repetitions) for the Jackknife procedure applying the
protected approach by selection using the FDR under the global Null: The
jackknife based AUCi as a function of the selection boundaries i (Figure (A)) as
well as the boxplot of the ﬁnal selection boundary ^ resulting from the jackknife
procedure (Figure (B)) for the situation of m = 1000, n = 50.
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Figure 4.28: Simulation results (500 repetitions) for the Jackknife procedure applying the
protected approach by selection using the FDR under the global Null: The
jackknife based AUCi as a function of the selection boundaries i (Figure (A)) as
well as the boxplot of the ﬁnal selection boundary ^ resulting from the jackknife
procedure (Figure (B)) for the situation of m = 1000, n = 100.
Figure 4.29: Simulation results (100 repetitions) for the Jackknife procedure applying the
protected approach by selection using the FDR under the global Null: The
jackknife based AUCi as a function of the selection boundaries i (Figure (A)) as
well as the boxplot of the ﬁnal selection boundary ^ resulting from the jackknife
procedure (Figure (B)) for the situation of m = 6000, n = 50.
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Figure 4.30: Simulation results (500 repetitions) for the Jackknife procedure applying the
optimistic approach by selection of the best k markers under the global Null:
The jackknife based AUCki as a function of the selection boundaries ki (Figure
(A)) as well as the boxplot of the ﬁnal selection boundary k^ resulting from the
jackknife procedure (Figure (B)) for the situation of m = 1000, n = 50.
Figure 4.31: Simulation results (100 repetitions) for the Jackknife procedure applying the
optimistic approach by selection of the best k markers under the global Null:
The jackknife based AUCki as a function of the selection boundaries ki (Figure
(A)) as well as the boxplot of the ﬁnal selection boundary k^ resulting from the
jackknife procedure (Figure (B)) for the situation of m = 6000, n = 50.
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Figure 4.32: Distribution of the jackknife AUC for selection using FDR (500 simulation steps):
me = 10, 60 or 0 among m = 1000 hypotheses. The sample size was set to
n = 50 per group (ﬁrst column) and n = 100 (second column).
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Figure 4.33: Distribution of the jackknife AUC for selection using FDR (100 simulation steps):
me = 10, 60 or 0 among m = 6000 hypotheses. The sample size was set to
n = 50 per group.
4.8 Variable Selection expecting a small AUC
In the last sections we assumed that the optimal linear prediction score of future patients,
if known, would lead to a ROC-curve crossing through the benchmark point where sensitiv-
ity and speciﬁcity are 0:9, which corresponds to a theoretically achievable AUC of 0:965
indicating a very good discrimination between responders and non-responders. However, in
medical research such AUC values may not be achieved. To investigate a more realistic sce-
nario, we also simulated the situation where the AUC is assumed to be 0:8, which is, e.g.,
achievable in predicting hospital mortality from scores based on a set of variable measured
in patients at admission to an intensive care unit (and constructed in large training samples,
see Metnitz et al. (2005a) and Metnitz et al. (2005b)). We only investigated simulations
for the protected approach using a multiple test controlling the FDR since we expect similar
tendencies for the other selection method by selecting the best k markers. To achieve a
future performance of AUC = 0:8 the benchmark point is at v = 1  w = 0:724 (assuming
a ROC crossing through a point, where sensitivity and speciﬁcity are the same). The minimal
 required to obtain this ROC is 0:38 assuming me = 10 alternatives and 0:15 for me = 60.
Figure 4.34 shows the minimal required  for diﬀerent values for AUC. Results assuming
10 (dashed line) and 60 (solid line) eﬀective markers are shown. The results for AUC = 0:8
and 0:965 (as assumed in the previous sections) are marked.
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Figure 4.34: Minimal required eﬀect size  as a function of AUC assuming me = 10 (dashed
line) and 60 (solid line)
4.8.1 Simulation results
We again performed simulations (10000 simulation steps) assuming me = 10 and 60 alter-
natives among m = 1000 and 6000 hypotheses. The sample size per group is set to n = 50,
100 and 500.
m=1000
Figure 4.35 shows the resulting AUC values expecting me = 10 among 1000 hypotheses ﬁxing
the sample size to n = 50 (Figure 4.35 (A)), 100 (Figure 4.35 (B)) and 500 (Figure 4.35
(C)) per group. Figure 4.35 (A) shows that applying a small sample size per group we will
not be able to ﬁnd good prediction scores whatever FDR is used for selection. The average
AUC values conditional that at least one marker is selected for future prediction vary around
0:6 over the whole investigated grid of FDRs. Note that if a FDR of 0:05 is chosen, in only
24:7% of the simulated samples a prediction score is selected. This percentage increases to
99% if the FDR is targeted with 0:95. Larger sample sizes are needed to detect the alter-
natives with their only small eﬀect sizes required to achieve AUC = 0:8. However, when
doubling the sample size to n = 100 per group (Figure 4.35 (B)) AUCsim only increases to
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0:676 and occurs for FDR= 0:5. Fixing the sample size to n = 500 leads to prediction scores
with AUCsim = 0:795 for a FDR of 0:005 and 0:01 which is only slightly smaller than AUC
of 0:8 (Figure 4.35 (C)).
Increasing the number of eﬀective markers to me = 60 hypotheses (Figures 4.36) again
a very large sample size is needed to achieve good prediction scores. However, ﬁxing the
sample size to n = 500 per group AUCsim is only 0:720 for a FDR between 0:4 and 0:5. For
n = 50 the average AUC values do not exceed 0:6 over the whole range of investigated FDR
values. For n = 100 per group AUCsim is 0:614 for FDR= 0:9.
m=6000
If the eﬀective markers are searched among 6000 hypotheses the situation gets extremely
worse if smaller sample sizes are considered (Figures 4.37 and 4.38). Increasing the sample
size to n = 500 per group helps if only a small number of alternatives with large eﬀect sizes is
assumed. Whereas for me = 10 (Figure 4.37 (C)) an AUCsim of 0:793 can be obtained if the
FDR is set to 0:05, for me = 60, AUCsim is only 0:657 for a FDR of 0:55 and 0:6 (Figure 4.38
(C)). Thus the conclusion is that if there is only a only moderate true discrimination between
responders and non-responders very large sample sizes are required to get good prediction
scores. Studies with small sizes will mostly produce useless prediction scores.
4.8.2 Jackknife procedure
m=1000, me=10
To investigate the jackknife procedure for the situation of a smaller AUC, we ﬁrst investigate
the scenario assuming me = 10 among m = 1000 for a sample size of n = 50 and n = 100
per group (500 simulation steps). Figures 4.39 show the results for n = 50. Figure 4.39 (A)
shows the jackknife based AUCi values as a function of the selection boundaries i . The
mean curve (solid curve) over the simulated samples is ﬂat over the investigated i values.
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The jackknife procedure results in a median ﬁnal selection boundary ^ of 0:0125 (mean:
0:0424, Figure 4.39 (B)) which corresponds to a median estimated ̂FDR of 0:763 (mean:
0:713, Figure (C)). The mean estimated ̂FDR is slightly larger than the mean actual FDR of
0:711 (median: 0:813). The diﬀerence between the estimated and the actual FDR is again
varying around 0 (see Figure 4.39 (D)). Note that the median asymptotic FDR^;1 is 0:774
(mean: 0:734). The ^ values found by the jackknife procedure lead to prediction scores with
a mean future AUC^(x) of 0:598 (Figure 4.39 (E)). The average AUC^ is 0:741. However,
the average proportion of at least one false positive (FWER^) is 0:910 (median: 1, Figure
4.39 (F)). The actual FWER calculated from the 500 simulation steps is 0:92. The similar
performance in terms of future AUC values over the whole range of investigated FDR values
with no explicit optimum clearly indicates no good condition to use the jackknife procedure.
Increasing the sample size to n = 100 the jackknife procedure found a median ﬁnal se-
lection boundary ^ of 0:009 (mean: 0:022) corresponding to a median actual FDR of 0:613
(mean: 0:555) leading to prediction scores with an average AUC^(x) of 0:665. Remember
that the AUCsim found from the simulation was 0:676 for FDR= 0:5. Note that the mean
jackknife AUC^ is 0:760.
m=1000, me=60
Assuming me = 60 alternatives among 1000 tested hypotheses, the jackknife procedure
results in a median ^ of 0:039 (mean: 0:139, see Figure 4.40 (B)) which corresponds to a
mean estimated ̂FDR of 0:815 (median: 0:852, Figure 4.40 (C)). The mean actual FDR of
0:779 (median: 0:833) is slightly smaller. The diﬀerence between both FDR values is again
varying around 0 (Figure 4.40 (D)). The mean asymptotic FDR^;1 is 0:781 (median: 0:797).
Figure 4.40 (E) shows that the selection boundaries selected by the jackknife procedure lead
to prediction scores with an average future AUC^(x) of 0:551. Note that AUCsim found in
the simulations is 0:583 when controlling a FDR of 0:90. The average AUC^ is 0:701. Note
that FWER^ is again very large with a mean value of 0:951 (median: 1) and the actual
FWER calculated from the simulated sample is 0:962.
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Global null hypothesis
Figure 4.41 describes the problem if the global null hypotheses is true. The Figures show
the distributions of the AUC^ values expecting me = 10, 60 and 0 alternatives assuming
AUC = 0:8 if the alternative holds. For me = 10 the shift of the distribution to the left is
about one standard deviation (a mean value of 0:741 compared to a mean value of 0:660
under the global null). Fixing the boundary for AUC^ to e.g. 0:7 for the basic decision to
construct a prediction score or not, in 26:6% of the simulated samples no prediction score
would be calculated from the samples even if in reality a prediction score exists. In case of
the global null hypotheses, for 32:6% of the simulated samples AUC^  0:7.
The shift between the distributions expecting me = 60 and the global null is only about one
half standard deviation (a mean value of 0:701 as compared to 0:660). Thus in case of a
moderate true discrimination between responders and non-responders (AUC = 0:8) and a
large number of eﬀective markers with small eﬀect sizes inducing this discrimination it may
become a formidable task to distinguish whether in reality the alternative or the global null
holds. However, the small jackknife AUC^ may also indicate that the eﬀect sizes under the
alternative are to small for the given sample size.
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Figure 4.35: Boxplots of the area under the ROC-Curve (10000 simulated samples) for se-
lection using the FDR approach assuming me = 10 alternatives markers among
m = 1000 tested markers. The sample size per group was set to n = 50 (Fig-
ure (A)), 100 (Figure (B)) and 500 (Figure (C)). AUC is given as dotdashed
horizontal line.  was set to 0:38.
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Figure 4.36: Boxplots of the area under the ROC-Curve (10000 simulated samples) for se-
lection using the FDR approach assuming me = 60 alternatives markers among
m = 1000 tested markers. The sample size per group was set to n = 50 (Fig-
ure (A)), 100 (Figure (B)) and 500 (Figure (C)). AUC is given as dotdashed
horizontal line.  was set to 0:15.
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Figure 4.37: Boxplots of the area under the ROC-Curve (10000 simulated samples) for se-
lection using the FDR approach assuming me = 10 alternatives markers among
m = 6000 tested markers. The sample size per group was set to n = 50 (Fig-
ure (A)), 100 (Figure (B)) and 500 (Figure (C)). AUC is given as dotdashed
horizontal line.  was set to 0:38.
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Figure 4.38: Boxplots of the area under the ROC-Curve (10000 simulated samples) for se-
lection using the FDR approach assuming me = 60 alternatives markers among
m = 6000 tested markers. The sample size per group was set to n = 50 (Fig-
ure (A)), 100 (Figure (B)) and 500 (Figure (C)). AUC is given as dotdashed
horizontal line.  was set to 0:15.
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Figure 4.39: Simulation results (500 repetitions) of the Jackknife procedure applying the
protected approach: AUCi as a function of i (Figure (A)) as well as boxplots of
the ﬁnal selection boundary ^ (B), the resulting estimated ̂FDR, actual FDR and
asymptotic FDR^ (C), the bias of the estimated FDR (D), the jackknife AUC^
and the future AUC^(x) (E) and FWER^ (F) for the situation of me = 10,
m = 1000, n = 50.
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Figure 4.40: Simulation results (500 repetitions) of the Jackknife procedure applying the
protected approach: AUCi as a function of i (Figure (A)) as well as boxplots of
the ﬁnal selection boundary ^ (B), the resulting estimated ̂FDR, actual FDR and
asymptotic FDR^ (C), the bias of the estimated FDR (D), the jackknife AUC^
and the future AUC^(x) (E) and FWER^ (F) for the situation of me = 60,
m = 1000, n = 50.
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Figure 4.41: Distribution of the jackknife AUC for selection using FDR assuming a hypothet-
ical AUC of 0:8 (500 simulation steps): me = 10, 60 or 0 among m = 1000
hypotheses. The sample size was set to n = 50 per group.
4.9 Discussion
If there is only a single marker candidate, to get a good prediction (ROC-Curve) the eﬀect
size has to be very large. Therefore only small samples are suﬃcient to identify this single
marker by a statistical comparison between responders and non responders. But this is not
the typical situation we face in such problems. Instead we generally are confronted with more
than one candidate. Often there are very large numbers of candidates, few of them being
eﬀective with rather small eﬀect sizes. Selection and estimation are often based on samples
dramatically smaller than the number of candidates so that the asymptotic of model selection
procedures does not apply. The estimates of the selected weights (and the ROC-curves) are
biased and highly variable.
We performed simulations for diﬀerent methods for selection of markers for future prediction.
In the situation where the sample sizes are much smaller than the number of markers the
simple method of additive scores following a selection of markers by multiple testing based
on a FDR threshold general outperforms selection by forward stepwise logistic regression.
The appearing problem of complete separation of data points results in selecting only a few
alternatives for future prediction and thus to a poor performance in terms of AUC values
for future independent patients. If the number of eﬀective markers is rather small and they
have suﬃciently large eﬀects, which, if all would be known, would lead to a large AUC, then
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the selected scores may have good properties over a range of diﬀerent FDR values used
for selection. Under the alternative in general it seems to be preferable to use rather lib-
eral selection criteria accepting that a certain number of nuisance markers is contained in
a score to get the advantage of catching more eﬀective ones. Even using the optimistic
rule of simply selecting a pre-ﬁxed number of "best" markers under the alternative may lead
to good predictions in terms of the AUC of the resulting score. For large samples the pre-
dictive ability of the estimated score does not depend strongly on the number of selected
markers. For large sample sizes the weights for ineﬀective markers contained in the score
are estimated more precisely and, despite of the selection procedure, will tend to be the ones
close to zero with a small contribution overall. Hence the performance of the score will not
vary much for diﬀerent numbers of ineﬀective markers contained in the score: More liberal
selection criteria will lead to scores containing more nuisance markers (with low weights) but
also more eﬀective ones (with large weights). This mirrors the fact that asymptotically for
large sample sizes, multiple test based selection procedures may be consistent procedures for
model selection. It also has to be mentioned, that if a very large number of eﬀective markers
is expected working together with rather small individual eﬀect sizes and only small sample
sizes are available, the two selection methods based on univariate tests also perform worse, al-
though leading to a larger AUC for future prediction than using the forward logistic regression.
The cruical scenario in the small sample case is the global null hypothesis: There are no
eﬀective markers at all and hence any selection will lead to completely uninformative predic-
tion scores. To protect against erroneous selection in this situation, e.g. the FDR applied
for selection should be rather small. Under the global null hypothesis control of the FDR also
controls the probability of the selection of any markers. Under the alternative, however, we
found that rather larger FDR values should be used for selection. The unprotected approach
will always select nuisance scores from the data.
One way to determine the FDR-value to be applied for selection in a concrete sample (or
simply the number k of the best markers to be selected) in order to achieve good prediction
by a prognostic score in terms of the AUC is to estimate the selection boundaries by jack-
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knife methodology. For a grid of diﬀerent selection thresholds we repeated the estimation of
the score in the n2 samples resulting from leaving out all n2 possible pairs of a single non-
responder and a single responder respectively. We then estimated the jackknife based AUCi
by counting how often in the n2 pairs left out from the respective training samples the score
derived from the corresponding training sample has the right order in magnitude between the
non-responder and the responder. The selection thresholds leading to the largest jackknife
based AUCi was used for selection in the total sample. This method seems to work if we
really are in a situation that we deal with markers with a high prognostic potential which leads
to rather large jackknife estimates of the AUC, whereas under the global null hypothesis these
estimates concentrate around 0:5.
However the situation gets much worse if we look at scenarios when the markers are not suf-
ﬁciently eﬀective that the optimal score (if known) would lead to a ROC-curve crossing the
point with sensitivity and speciﬁcity of 0:9 (with a theoretically best achievable AUC = 0:965
which was the benchmark in most of our investigations). There may be biological situations
where markers of that predictive potential can be expected. For AUC close to values of 0:8,
which are values, e.g., achievable in predicting hospital mortality from scores based on a set
of variable measured in patients at admission to an intensive care unit, the selection proce-
dure will lead to poor scores. Also jackknife estimation procedure of the AUC to determine
the selection thresholds will require much larger samples in order to produce good selection
thresholds.
With this cross validation method we may achieve several goals:
1. We determine an optimal selection threshold for selection of markers to be used in a
prediction score for future sample units which provides a good performance in terms of
the ROC-curve.
2. We get a positively biased estimate of the AUC which is closer to the true AUC for
prediction the larger the eﬀect and sample sizes.
3. If the estimate of the AUC is small this may be an indication that in a speciﬁc sample
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we are close to the global null hypothesis or the eﬀect sizes are to small for the given
sample size.
4. We also get an estimate of the FDR among the selected markers which is close to the
true FDR (with a direction depending on the magnitude of the FDR).
Our ﬁndings show that simple methods can lead to well performing prediction scores even
in rather small samples, given that we deal with a problem where markers with noticeable
eﬀects are involved. However, they also tell us that there is no such thing as a free lunch in
a statistically odd problem of dealing with large numbers of variables considerably exceeding
sample sizes.
In this thesis we did not consider the situation of unknown variances or correlation between
the hypotheses since it would go beyond the scope of this work. However these topics are
object of our future scientiﬁc work.
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A Abstract
Motivation:
Two problems that arise in the genomic or proteomic context are to ﬁnd diﬀerentially ex-
pressed genes (proteins) among a large number of hypotheses and to ﬁnd prognostic scores
to predict a clinical outcome for future patients. Referring to the ﬁrst problem, it has been
shown, that two-stage pilot and integrated designs are powerful tools for investigating large
numbers of hypotheses. In modern genetic studies often the costs per observation diﬀer
between stages, because speciﬁc experimental devices have to be produced at higher costs
per measurement for the selected markers in the second stage. There is also an increasing
focus on using a less accurate assay in early stages and more accurate, but more expensive
ones in later stages for cost reasons. Asymptotically optimal two-stage designs controlling
the Family Wise Error or False Discovery Rate are considered when costs and eﬀect sizes
per measurement diﬀer between stages and total costs are constrained.
Investigating the second mentioned problem it seems that for a lot of medical research
reported in this ﬁeld there has been insuﬃcient awareness of the statistical properties of
the resulting prognostic scores. We looked at the statistical properties of such scores in
terms of how well they can predict the outcome of a medical therapy in future patients in
terms of the area under the receiver operating characteristics (AUC).
Results:
For the practically relevant case that the same method is applied at both stages but design-
ing the second stage measurements raises extra costs, two-stage designs are more powerful
than the single-stage design even for large costs ratios. The power of the optimal pilot
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and integrated two-stage designs generally are similar, however the integrated approach
is less sensitive even to severe design misspeciﬁcations in the planning phase. Depending
on the cost and eﬀect size ratios between the measurements it is generally more powerful
to apply two-stage procedures using one measurement method at both stages. Switching
from a low-cost standard method to a high-cost improved method may only be advisable
if there is lack of resources, so that the ﬁrst-stage sample size for the high-cost method
would be too small.
Selection and estimation are often based on samples dramatically smaller than the number
of candidates so that the asymptotic of model selection procedures (sample size goes to
inﬁnity) does not apply. The estimates of the selected weights are biased and highly vari-
able. If there are in fact eﬀective markers among many candidates, prediction seems to be
better if the selection procedures allows to include some ineﬀective markers in the score.
If there are no eﬀective markers at all, that means the global null hypothesis is true, then
applying a liberal selection procedure tends to create pseudo scores which have no prog-
nostic value at all. The best threshold to be used in selection of the prediction score which
provides the largest AUC varies over diﬀerent parameter constellations (varying number of
tested markers, proportion of alternatives or sample size). We considered cross validation
to determine the optimal selection criterion in a speciﬁc sample. For that purpose we used
a modiﬁed jackknife procedure. This procedure allows choosing an appropriate selection
criterion for constructing a prediction score and at the same time provides an estimate for
the extent of false positive decisions. Moreover, this procedure by leading to low jackknife
AUCs may indicate that in a particular data set we are close to the global null hypotheses
or the eﬀects are to small for the given sample size.
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Motivation:
In genetischen Studien triﬀt man häuﬁg auf zwei Probleme: Erstens versucht man Gene
(oder Proteine) zu ﬁnden die zum Beispiel bei bestimmten Krankheiten im Vergleich zu
gesunden Personen verschieden ausgeprägt sind. Andererseits versucht man aus solchen
Genen (Proteinen) prognostische Scores für den klinischen Ausgang zum Beispiel einer
Therapie eines Patienten zu ﬁnden. Schon in früheren Publikationen wurde gezeigt, dass
Zwei-Stufen Pläne, wie das Pilot oder das Integrated Design geeignete Methoden sind um
eine große Anzahl von Hypothesen zu testen, wie es in solchen Studien der Fall ist. In
genetischen Studien kann es vorkommen, dass die Kosten pro Beobachtung zwischen den
beiden Stufen unterschiedlich sind, wenn zum Beispiel spezielle Chips für die Untersuchung
von selektierten Genen angefertigt werden müssen. In neueren Studien kommt es auch
immer öfter vor, dass in der ersten Stufe ein billiges Standardverfahren und in der zweiten
Stufe teureres, aber dafür genaueres Verfahren verwendet wird. Für solche Zwei-Stufen
Pläne, in denen Kosten und Methoden zwischen den Stufen variieren, werden asymptotisch
optimale Parameter untersucht. Es soll entweder die False Discovery Rate oder der Family
Wise Error einhalten werden.
Bezugnehmend auf das zweite angeführte Problem gibt es für viele medizinische Unter-
suchungen in diesem Gebiet nur mangelhafte Erkenntnisse über die statistischen Eigen-
shaften prognostischer Scores, die auf Basis von genetischen Datensätzen entwickelt wer-
den. Solche statistische Eigenschaften, das heißt wie gut ein Score, der aufgrund eines
Trainigsdatensatzes erstellt wurde, den Ausgang einer Therapie eines zukünftigen Patien-
ten vorhersagt, werden untersucht. Es wird dabei die "area under the receiver operating
characteristic" (AUC) als Kriterium verwendet.
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Ergebnisse:
Unterscheiden sich nur die Kosten pro Beobachtung zwischen den Stufen, zahlt sich auch
bei einem beachtlichen Kostenverhältnis zwischen den beiden Stufen die Anwendung von
Zwei-Stufen Verfahren aus (im Sinne von höherer Power). Die Power der optimalen Pilot
und Integrated Designs ist zwar ähnlich hoch, das Integrated Design ist allerdings robuster
gegen Fehleinschätzungen der Parameter in der Planungsphase. Im Allgemeinen führen
Zwei-Stufen Pläne, die die gleiche Methode in beiden Stufen verwenden, zu einer höheren
Power (in Abhängigkeit von Kosten- und Eﬀektgrößenverhältis), als Pläne, bei denen die
Methode in der zweiten Stufe geändert wird. Letztere Pläne zahlen sich nur aus, wenn
die teurere Methode aufgrund von fehlenden ﬁnanziellen Mitteln in der ersten Stufe nicht
verwendet werden kann.
Die Selektion von wirksamen Genen (Proteinen) und somit die Aufstellung von prognostis-
chen Scores hängt sehr oft von den Trainigsdaten ab, bei denen die Stichprobengröße oft
drastisch kleiner ist als die Anzahl der untersuchten Hypothesen, so dass die Asymptotik
(Stichprobenumfang geht gegen unendlich) von Modellselektionsprozeduren nicht mehr
stimmt. Diese Scores sind daher verzerrt und sehr variabel. Wenn tatsächlich mehrere ef-
fektive Marker existieren stellt es sich heraus, dass es besser ist liberalere Selektionskiterien
zu verwenden und somit auch einige (oft sogar viele) ineﬀektive Marker in den Score mit
aufzunehmen. Gilt allerdings die Globale Nullhypothese führen solche liberalen Kriterien
dazu, dass Pseudo-Scores erstellt werden, die keinen prognostischen Wert haben. Das
beste Selektionskriterium um einen prognostischen Score mit einer hohen AUC zu erzeu-
gen ist allerdings von Parametern wie der Anzahl der insgesamt gestesteten Hypothesen,
der Stichprobengröße oder dem Anteil der eﬀektiven Marker abhängig. Wir testeten eine
modiﬁzierte Jackknife Methode um das optimal Selektionskriterium zu ﬁnden. Es stellt
sich heraus, dass diese Methode ein geeignetes Selektionskriterium ﬁndet und zusätzlich
Informationen über die Anzahl der falsch-positiven Entscheidungen liefert. Darüber hinaus
bekommt man durch kleine Jackknife-AUC Werte einen Hinweis darauf, dass man sich in
einem speziﬁschen Datensatz in der "Nähe" der globale Nullhypothese beﬁndet oder dass
die Eﬀekte für den gegebenen Stichprobenumfang zu kein sind.
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D R-Code
The R-Programs for the two-stage pilot and integrate designs controlling the FWER or FDR include
the following parameters.
Parameters:
TotalC ... ﬁxed overall total costs C
c2 ... cost ratio c2 between both stages
r ... fraction r of C used in the ﬁrst stage
m1 ... number of hypotheses m1
pi0 ... proportion of true null hypotheses 0 among all m1 hypotheses
alpha ... targeted false discovery rate 
ga1 ... ﬁrst stage selection boundary 1
ga2 ... second stage rejection boundary 2 for the pilot design
ga ... second stage rejection boundary  for the integrated design
delta ... eﬀect size 
kr ... eﬀect size ratio k between both stages
n1 ... ﬁrst stage sample size n1
n2 ... second stage sample size n2
dparms ... =c(r,ga1) vector containing the two design parameters r and 1
ivga1 ... initial value of 1 for optimization
ivr ... initial value of r for optimization
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D.1 The pilot design controlling the FWER
This in an R-Program to compute the asymptotically optimal design parameters r and 1 as well
as the power
∏
p for a TWO-STAGE PILOT DESIGN controlling the FWER.
Functions:
optpilotfwe ... function to compute (-1)*(asymptotically optimal power)
-> minimization criteria for optimization
pilotfwe ... function to compute the asymptotically optimal design parameters
r and 1
R-Code:
optpilotfwe<-function(dparms,m1,pi0,delta,kr,alpha,TotalC,c2)
{
r<-dparms[1]
ga1<-dparms[2]
n1<-r*TotalC/m1
powerst1<-1-pnorm(qnorm(1-ga1)-delta*sqrt(n1))
m2<-m1*(1-pi0)*powerst1+m1*pi0*ga1
ga2<-alpha/m2
n2<-(1-r)*TotalC/c2/m2
powerst2<-1-pnorm(qnorm(1-ga2)-delta*kr*sqrt(n2))
-powerst1*powerst2
}
pilotfwe<-function(m1,pi0,delta,kr,alpha,TotalC,c2,ivr,ivga1)
{
optpilot <-optim(c(ivr,ivga1),fn=optpilotfwe,m1=m1,pi0=pi0,delta=delta,kr=kr,
alpha=alpha,TotalC=TotalC,c2=c2,method="L-BFGS-B",
lower=c(0.00000001,0.00000001),upper=c(0.999999,0.999999))
r<-optpilot[[1]][1]
ga1<-optpilot[[1]][2]
totalpower<optpilot[[2]]
result<-round(c(r,ga1,totalpower),3)
names(result)<-c("r","gamma1","Power")
result
}
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D.2 The pilot design controlling the FDR
This in an R-Program to compute the asymptotically optimal design parameters r and 1 as well
as the power
∏
p for a TWO-STAGE PILOT DESIGN controlling the FDR.
Functions:
pfdr.fun ... function to compute the asymptotic FDR alpha as a function of 1 and 2
bspilotfdr ... function to compute 2 for given 1 and 
optpilotfdr ... function to compute (-1)*(asymptotically optimal power)
->minimization criteria for optimization
pilotfdr ... function to compute the asymptotically optimal design
parameters r and 1
R-Code:
pfdr.fun<-function(pi0,ga1,ga2,n1,n2,delta,kr)
{
powerst1<-1-pnorm(qnorm(1-ga1),mean=delta*sqrt(n1),sd=1)
powerst2<-1-pnorm(qnorm(1-ga2),mean=delta*kr*sqrt(n2),sd=1)
alpha<-pi0*ga1*ga2/(pi0*ga1*ga2+(1-pi0)*powerst1*powerst2)
alpha
}
bspilotfdr<-function(alpha,pi0,ga1,n1,n2,delta,kr)
{
ga2a<-0.0000000001
ga2b<-0.999999
i<-100
while (i>0) {
ga2c<-(ga2a+ga2b)/2
alphaze<-pfdr.fun(pi0=pi0,ga1=ga1,ga2=ga2c,n1=n1,n2=n2,delta=delta,kr=kr)
ga2a<-ifelse(alphaze<=alpha,ga2c,ga2a)
ga2b<-ifelse(alphaze<=alpha,ga2b,ga2c)
i<-i-1 }
ga2c
}
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optpilotfdr<-function(dparms,m1,pi0,delta,kr,alpha,TotalC,c2)
{
r<-dparms[1]
ga1<-dparms[2]
n1<-r*TotalC/m1
powerst1<-1-pnorm(qnorm(1-ga1),mean=delta*sqrt(n1),sd=1)
m2<-m1*(1-pi0)*powerst1+m1*pi0*ga1
n2<-(1-r)*TotalC/c2/m2
ga2<-bspilotfdr(alpha,pi0,ga1,n1,n2,delta,kr)
powerst2<-1-pnorm(qnorm(1-ga2),mean=delta*kr*sqrt(n2),sd=1)
-powerst1*powerst2
}
pilotfdr<-function(m1,pi0,delta,kr,alpha,TotalC,c2,ivr,ivga1)
{
optpilot<-optim(c(ivr,ivga1),fn=optpilotfdr,m1=m1,pi0=pi0,delta=delta,kr=kr,
alpha=alpha,TotalC=TotalC,c2=c2,method="L-BFGS-B",
lower=c(0.00000001,0.00000001),upper=c(0.999999,0.999999))
r<-optpilot[[1]][1]
ga1<-optpilot[[1]][2]
totalpower<optpilot[[2]]
result<-round(c(r,ga1,totalpower),3)
names(result)<-c("r","gamma1","Power")
result
}
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D.3 The integrated design controlling the FWER
This in an R-Program to compute the asymptotically optimal design parameters r and 1 as well
as the power
∏
int for a TWO-STAGE INTEGRATED DESIGN controlling the FWER.
Functions:
powerintfwe ... function to compute the asymptotic power of the integrated design
(without integration over z)
gintfwe ... function to compute s for given  and 1 of the integrated design
(without integration over z)
bsintfwe ... function to compute  for given 1 and 
optintfwe ... function to compute (-1)*(asymptotically optimal power)
-> minimization criteria for optimization
integratedfwe ... function to compute the asymptotically optimal design parameters r and 1
R-Code:
powerintfwe<-function(z,ga,n1,n2,delta,kr)
{
w1<-n1/(n1+n2*kr2)
(1-pnorm ((qnorm(1-ga)-sqrt(w1)*z)/sqrt(1-w1),mean=(sqrt(n2)*delta),sd=1))
*dnorm(z,mean=sqrt(n1)*delta*kr,sd=1)
}
gintfwe<-function(z,ga,n1,n2,kr)
{
w1<-n1/(n1+n2*kr2)
(1-pnorm((qnorm(1-ga)-sqrt(w1)*z)/sqrt(1-w1)))*dnorm(z)
}
bsintfwe<-function(alpha,m1,ga1,n1,n2,delta,kr)
{
gas<-alpha/m1
gaa<-0.0000000001
gab<-0.999999
i<-100
while (i>0) {
gac<-(gaa+gab)/2
gammaze<-integrate(gintfwe,lower=qnorm(1-ga1),upper=Inf,ga=gac,n1=n1,n2=n2,kr=kr)[[1]]
gaa<-ifelse(gammaze<=gas,gac,gaa)
gab<-ifelse(gammaze<=gas,gab,gac)
i<-i-1 }
gac
}
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optintfwe<-function(dparms,delta,kr,alpha,m1,TotalC,c2,pi0)
{
r<-dparms[1]
ga1<-dparms[2]
n1<-TotalC*r/m1
m2<-m1*(pi0*ga1+(1-pi0)*(1-pnorm(qnorm(1-ga1),mean=delta*sqrt(n1))))
n2<-(1-r)*TotalC/c2/m2
ga<-bsintfwe(alpha=alpha,m1=m1,ga1=ga1,n1=n1,n2=n2,delta=delta,kr=kr)
powerint<-integrate(powerintfwe,qnorm(1-ga1),Inf,ga=ga,n1=n1,n2=n2,delta=delta,kr=kr)[[1]]
-powerint
}
integratedfwe<-function(m1,pi0,delta,kr,alpha,TotalC,c2,ivr,ivga1)
{
optint<-optim(c(ivr,ivga1),fn=optintfwe,m1=m1,pi0=pi0,delta=delta,kr=kr,
alpha=alpha,TotalC=TotalC,c2=c2,method="L-BFGS-B",
lower=c(0.00000001,0.00000001),upper=c(0.999999,0.999999))
r<-optint[[1]][1]
ga1<-optint[[1]][2]
totalpower<- -optint[[2]]
result<-round(c(r,ga1,totalpower),3)
names(result)<-c("r","gamma1","Power")
result
}
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D.4 The integrated design controlling the FDR
This in an R-Program to compute the asymptotically optimal design parameters r and 1 as well
as the power
∏
int for a TWO-STAGE INTEGRATED DESIGN controlling the FDR.
Functions:
powerintfdr ... function to compute the asymptotic power of the integrated design
(without integration over z)
gintfdr ... function to compute s for given  and 1 of the integrated design
(without integration over z)
intfdr.fun ... function to compute the asymptotic FDR alpha as a function of  and 1
bsintfdr ... function to compute  for given 1 and 
optintfdr ... function to compute (-1)*(asymptotically optimal power)
-> minimization criteria for optimization
integratedfdr ... function to compute the asymptotically optimal design parameters r and 1
R-Code:
powerintfdr<-function(z,ga,n1,n2,delta,kr)
{
w1<-n1/(n1+n2*kr2)
(1-pnorm((qnorm(1-ga)-sqrt(w1)*z)/sqrt(1-w1),mean=(sqrt(n2)*kr*delta),sd=1))
*dnorm(z,mean=sqrt(n1)*delta,sd=1)
}
gintfdr<-function(z,ga,n1,n2,kr)
{
w1<-n1/(n1+n2*kr2)
(1-pnorm((qnorm(1-ga)-sqrt(w1)*z)/sqrt(1-w1)))*dnorm(z)
}
intfdr.fun<-function(pi0,ga1,ga,n1,n2,delta,kr)
{
gs<-integrate(gintfdr,lower=qnorm(1-ga1),upper=Inf,ga=ga,n1=n1,n2=n2,kr=kr)[[1]]
powint<-integrate(powerintfdr,lower=qnorm(1-ga1),upper=Inf,ga=ga,n1=n1,n2=n2,
delta=delta,kr=kr)[[1]]
alpha<-pi0*gs/(pi0*gs+(1-pi0)*powint)
alpha
}
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bsintfdr<-function(alpha,pi0,ga1,n1,n2,delta,kr)
{
gaa<-0.0000000001
gab<-0.999999
i<-100
while (i>0) {
gac<-(gaa+gab)/2
alphaze<-intfdr.fun(pi0=pi0,ga1=ga1,ga=gac,n1=n1,n2=n2,delta=delta,kr=kr)
gaa<-ifelse(alphaze<=alpha,gac,gaa)
gab<-ifelse(alphaze<=alpha,gab,gac)
i<-i-1 }
gac
}
optintfdr<-function(dparms,delta,kr,alpha,m1,TotalC,c2,pi0)
{
r<-dparms[1]
ga1<-dparms[2]
n1<-TotalC*r/m1
m2<-m1*(pi0*ga1+(1-pi0)*(1-pnorm(qnorm(1-ga1),mean=delta*sqrt(n1))))
n2<-(1-r)*TotalC/c2/m2
ga<-bsintfdr(alpha=alpha,pi0=pi0,ga1=ga1,n1=n1,n2=n2,delta=delta,kr=kr)
powerint<-integrate(powerintfdr,qnorm(1-ga1),Inf,ga=ga,n1=n1,n2=n2,delta=delta,kr=kr)[[1]]
-powerint
}
integratedfdr<-function(m1,pi0,delta,kr,alpha,TotalC,c2,ivr,ivga1)
{
optint<-optim(c(ivr,ivga1),fn=optintfdr,m1=m1,pi0=pi0,delta=delta,kr=kr,
alpha=alpha,TotalC=TotalC,c2=c2,method="L-BFGS-B",
lower=c(0.00000001,0.00000001),upper=c(0.999999,0.999999))
r<-optint[[1]][1]
ga1<-optint[[1]][2]
totalpower<- -optint[[2]]
result<-round(c(r,ga1,totalpower),3)
names(result)<-c("r","gamma1","Power")
result
}
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The following tables show simulation results for the diﬀerent selection procedures for con-
structing a linear score discussed in Section 4.3. Diﬀerent FDR's for using the protected
procedure, diﬀerent numbers k of "best" markers for using the optimistic procedure and
diﬀerent boundaries  when using the forward logistic regression as selection method are
investigated.
The average number of selected true null hypothesis (ms0SD), the average number of
selected alternatives (mseSD) and the average future AUC (SD) conditional that at
least one marker was identiﬁed for future prediction are given in the tables for the diﬀer-
ent scenarios. The proportion of samples among all simulations steps where at least one
marker has been identiﬁed for future prediction, p^s , is only given in the tables concerning
the logistic regression and the protected approach, since in the optimistic approach p^s  1.
The number of alternatives is assumed to be me = 10 and 60 among m = 1000 and 6000
tested hypotheses. The sample size is set to n = 50, 100 and 500 per group.
E.1 Simulation results for the optimistic approach
Table E.1: Simulation results for the optimistic approach:
me = 10,  = 0:81, n = 50 per group, m = 1000 and 6000.
m = 1000 m = 6000
best ms0 (SD) m
s
e (SD) AUC (SD) m
s
0 (SD) m
s
e (SD) AUC (SD)
2 0.00 (0.04) 2.00 (0.04) 0.790 (0.005) 0.01 (0.11) 1.99 (0.11) 0.789 (0.014)
5 0.04 (0.20) 4.96 (0.20) 0.897 (0.010) 0.20 (0.45) 4.80 (0.45) 0.889 (0.023)
8 0.44 (0.63) 7.56 (0.63) 0.936 (0.015) 1.14 (0.95) 6.86 (0.95) 0.917 (0.028)
10 1.39 (0.89) 8.61 (0.89) 0.942 (0.016) 2.40 (1.12) 7.60 (1.12) 0.919 (0.028)
15 5.64 (0.75) 9.36 (0.75) 0.935 (0.014) 6.59 (1.08) 8.41 (1.08) 0.910 (0.026)
20 10.41 (0.63) 9.59 (0.63) 0.926 (0.013) 11.25 (1.01) 8.75 (1.01) 0.898 (0.025)
25 15.30 (0.53) 9.71 (0.53) 0.918 (0.012) 16.03 (0.94) 8.97 (0.94) 0.887 (0.024)
30 20.23 (0.47) 9.78 (0.47) 0.910 (0.012) 20.88 (0.88) 9.12 (0.88) 0.876 (0.023)
35 25.18 (0.43) 9.82 (0.43) 0.903 (0.013) 25.78 (0.84) 9.22 (0.84) 0.867 (0.023)
40 30.15 (0.39) 9.85 (0.39) 0.897 (0.013) 30.70 (0.80) 9.30 (0.80) 0.859 (0.022)
50 40.11 (0.33) 9.89 (0.33) 0.887 (0.013) 40.58 (0.74) 9.42 (0.74) 0.844 (0.021)
60 50.08 (0.28) 9.92 (0.28) 0.878 (0.013) 50.49 (0.68) 9.51 (0.68) 0.832 (0.021)
100 90.03 (0.18) 9.97 (0.18) 0.855 (0.014) 90.30 (0.54) 9.70 (0.54) 0.797 (0.019)
1000 990.00 (0.00) 10.00 (0.00) 0.752 (0.015) 990.01 (0.11) 9.99 (0.11) 0.675 (0.012)
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Table E.2: Simulation results for the optimistic approach:
me = 10,  = 0:81, n = 100 per group, m = 1000 and 6000.
m = 1000 m = 6000
best ms0 (SD) m
s
e (SD) AUC (SD) m
s
0 (SD) m
s
e (SD) AUC (SD)
2 0.00 (0.01) 2.00 (0.01) 0.791 (0.001) 0.00 (0.01) 2.00 (0.01) 0.791 (0.001)
5 0.00 (0.01) 5.00 (0.01) 0.899 (0.001) 0.00 (0.02) 5.00 (0.02) 0.899 (0.001)
8 0.00 (0.05) 8.00 (0.05) 0.946 (0.001) 0.01 (0.10) 7.99 (0.10) 0.946 (0.002)
10 0.09 (0.29) 9.91 (0.29) 0.962 (0.003) 0.24 (0.46) 9.76 (0.46) 0.960 (0.006)
15 5.01 (0.09) 9.99 (0.09) 0.954 (0.002) 5.05 (0.21) 9.95 (0.21) 0.950 (0.004)
20 10.00 (0.09) 10.00 (0.09) 0.948 (0.003) 10.02 (0.16) 9.97 (0.16) 0.941 (0.004)
25 15.00 (0.05) 10.00 (0.05) 0.942 (0.003) 15.02 (0.13) 9.98 (0.13) 0.932 (0.005)
30 20.00 (0.04) 10.00 (0.04) 0.938 (0.004) 20.01 (0.11) 9.99 (0.11) 0.925 (0.005)
35 25.00 (0.03) 10.00 (0.03) 0.934 (0.004) 25.01 (0.10) 9.99 (0.10) 0.918 (0.006)
40 30.00 (0.02) 10.00 (0.02) 0.930 (0.005) 30.01 (0.08) 9.99 (0.08) 0.911 (0.006)
50 40.00 (0.02) 10.00 (0.02) 0.923 (0.005) 40.01 (0.07) 10.00 (0.07) 0.900 (0.007)
60 50.00 (0.01) 10.00 (0.01) 0.918 (0.006) 50.00 (0.06) 10.00 (0.06) 0.890 (0.008)
100 90.00 (0.01) 10.00 (0.01) 0.902 (0.007) 90.00 (0.04) 10.00 (0.04) 0.860 (0.009)
1000 990.00 (0.00) 10.00 (0.00) 0.816 (0.011) 990.00 (0.00) 10.00 (0.00) 0.733 (0.010)
Table E.3: Simulation results for the optimistic approach:
me = 10,  = 0:81, n = 500 per group, m = 1000 and 6000.
m = 1000 m = 6000
best ms0 (SD) m
s
e (SD) AUC (SD) m
s
0 (SD) m
s
e (SD) AUC (SD)
10 0 (0) 10 (0) 0.965 (0.000) 0 (0) 10 (0) 0.965 (0.000)
15 5 (0) 10 (0) 0.963 (0.000) 5 (0) 10 (0) 0.962 (0.000)
20 10 (0) 10 (0) 0.962 (0.000) 10 (0) 10 (0) 0.960 (0.000)
25 15 (0) 10 (0) 0.961 (0.001) 15 (0) 10 (0) 0.958 (0.001)
30 20 (0) 10 (0) 0.960 (0.001) 20 (0) 10 (0) 0.957 (0.001)
35 25 (0) 10 (0) 0.959 (0.001) 25 (0) 10 (0) 0.955 (0.001)
40 30 (0) 10 (0) 0.958 (0.001) 30 (0) 10 (0) 0.954 (0.001)
50 40 (0) 10 (0) 0.957 (0.001) 40 (0) 10 (0) 0.951 (0.001)
60 50 (0) 10 (0) 0.955 (0.001) 50 (0) 10 (0) 0.949 (0.001)
100 90 (0) 10 (0) 0.952 (0.001) 90 (0) 10 (0) 0.940 (0.002)
1000 990 (0) 10 (0) 0.923 (0.003) 990 (0) 10 (0) 0.875 (0.004)
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